UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark one)
xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
  
For the quarterly period ended March 31,June 30, 2005
  
or
  
¨oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
  
For the transition period from ____________ to ____________.

Commission File Number:000-24248

AMERICAN TECHNOLOGY CORPORATION
(Exact name of registrant as specified in its charter)

Delaware87-0361799


(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification Number)
  
13114 Evening Creek Drive South, San Diego, California92128


(Address of principal executive offices)(Zip Code)
 
(858) 679-2114

(Registrant’s telephone number, including area code) 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YESx  YESNO o NO

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). YESx  NO o

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of April 28,August 2, 2005.

Common Stock, $0.00001 par value21,317,23924,239,840


(Class)(Number of Shares)

1



AMERICAN TECHNOLOGY CORPORATION

INDEX

 Page
PART I. FINANCIAL INFORMATION3
 
 Item 1. Financial Statements:3
 
  Balance Sheets as of March 31,June 30, 2005 and September 30, 2004 (unaudited)3
 
  Statements of Operations for the three and sixnine months ended March 31,June 30, 2005 and 2004 (unaudited)4
 
  Statements of Cash Flows for the sixnine months ended March 31,June 30, 2005 and 2004 (unaudited)5
 
  Notes to Interim Financial Statements (unaudited)6
 
 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations1416
 
 Item 3. Quantitative and Qualitative Disclosures about Market Risk38
 
 Item 4. Controls and Procedures3938
 
PART II. OTHER INFORMATION4039
 
 Item 1. Legal Proceedings4039
 
 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds4039
 
 Item 3. Defaults upon Senior Securities4039
 
 Item 4. Submission of Matters to a Vote of Security Holders40
 
 Item 5. Other Information40
 
 Item 6. Exhibits4041
 
SIGNATURES4142
EXHIBIT INDEX43

2


PART I. FINANCIAL INFORMATION

Item 1. Financial Statements.

American Technology Corporation
BALANCE SHEETS
Unaudited(Unaudited)

March 31,
2005

 September 30,
2004 (a)

 
ASSETS      
Current Assets:    
  Cash$6,162,409 $4,178,968 
  Trade accounts receivable, less allowance for doubtful accounts of
     $25,000 in each period
 494,503  926,747 
  Inventories, net 904,710  651,095 
  Prepaid expenses and other 186,192  156,419 
  Prepaid transaction costs 1,036,184   


Total current assets 8,783,998  5,913,229 
Equipment, net 683,912  453,355 
Patents, net 1,336,515  1,278,707 


Total assets$10,804,425 $7,645,291 


 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:      
 Accounts payable$1,617,191 $1,300,075 
 Accrued liabilities:      
   Payroll and related 480,115  302,706 
   Deferred revenue 300,000  322,344 
   Warranty reserve 238,837  331,917 
   Legal settlements 291,466  150,000 
   Other 42,959  22,236 
Capital lease short-term portion 11,631  10,967 
Derivative instrument 1,111,036 


Total current liabilities 4,093,235  2,440,245 
 
Long-Term Liabilities:
8% Unsecured Subordinated Promissory Notes, net of $645,184
  and $-0- debt discount
 1,354,816   
Capital lease long-term portion 5,203  12,131 


Total liabilities 5,453,254  2,452,376 


 
Commitments and contingencies
Stockholders equity    
Preferred stock, $0.00001 par value; 5,000,000 shares authorized:
  Series D Preferred stock 250,000 shares designated: 0 and 50,000
    issued and outstanding, respectively. Liquidation
    preference of $0 and $572,500, respectively.
    
  Series E Preferred stock 350,000 shares designated: 0 and 233,250
    issued and outstanding, respectively. Liquidation preference
    of $0 and $2,556,000, respectively.
   3 
Common stock, $0.00001 par value; 50,000,000 shares authorized;
  21,317,239 and 19,808,819 shares issued and outstanding respectively.
 213  198 
Additional paid-in capital 50,818,317  47,520,207 
Accumulated deficit (45,467,359) (42,327,493)


Total stockholders equity 5,351,171  5,192,915 


Total liabilities and stockholders equity$10,804,425 $7,645,291 


See accompanying notes to interim financial statements.

 June 30,
2005
 September 30,
2004 (a)
 


ASSETS      
Current Assets:      
  Cash$2,369,591 $4,178,968 
  Trade accounts receivable, less allowance of
    $105,000 and $25,000 for doubtful accounts, respectively
 507,308  926,747 
  Inventories, net 1,571,620  651,095 
  Prepaid expenses and other 329,576  156,419 
  Prepaid transaction costs 659,846   


Total current assets 5,437,941  5,913,229 
Equipment, net 692,865  453,355 
Patents, net 1,355,153  1,278,707 


Total assets$7,485,959 $7,645,291 


       
LIABILITIES AND STOCKHOLDERS’ EQUITY      
Current Liabilities:      
 Accounts payable$2,121,358 $1,300,075 
 Accrued liabilities:      
   Payroll and related 561,338  302,706 
   Deferred revenue 450,000  322,344 
   Warranty reserve 228,487  331,917 
   Legal settlements   150,000 
   Other 39,890  22,236 
Capital lease short-term portion 11,828  10,967 
Derivative instrument 659,846   


Total current liabilities 4,072,747  2,440,245 
Long-Term Liabilities:      
8% Unsecured Subordinated Promissory Notes, net of $553,447
  and $0 debt discount
 1,446,553   
Capital lease long-term portion 3,148  12,131 


Total liabilities 5,522,448  2,452,376 


Commitments and contingencies      
      
Stockholders’ equity      
Preferred stock, $0.00001 par value; 5,000,000 shares authorized:      
  Series D Preferred stock 250,000 shares designated: 0 and 50,000
    issued and outstanding, respectively. Liquidation
    preference of $0 and $572,500, respectively.
    
  Series E Preferred stock 350,000 shares designated: 0 and 233,250
    issued and outstanding, respectively. Liquidation preference
    of $0 and $2,556,000, respectively.
   3 
Common stock, $0.00001 par value; 50,000,000 shares authorized;
  21,336,489 and 19,808,819 shares issued and outstanding respectively.
 213  198 
Additional paid-in capital 51,023,426  47,520,207 
Accumulated deficit (49,060,128) (42,327,493)


Total stockholders’ equity 1,963,511  5,192,915 


Total liabilities and stockholders’ equity$7,485,959 $7,645,291 



(a) Derived from the audited financial statements as of September 30, 2004.


  See accompanying notes to interim financial statements.
 (a) Derived from the audited financial statements as of September 30, 2004.

3


American Technology Corporation
STATEMENTS OF OPERATIONS
(Unaudited)

For the three months ended June 30,
 
For the nine months ended June 30,
 
For the three months ended
March 31,

For the six months ended
March 31,


 
 
2005
 2004
 2005
 2004
 
2005
  
2004
  
2005
  
2004
  
        



Revenues:                    
Product sales$2,814,293 $1,493,250 $7,161,206 $2,111,834 $1,378,648 $2,089,359 $8,539,855 $4,201,193 
Contract and license 3,100    65,100  156,194  15,149  17,922  80,249  174,116 








Total revenues 2,817,393  1,493,250  7,226,306  2,268,028  1,393,797  2,107,281  8,620,104  4,375,309 
Cost of revenues 1,453,966  945,224  2,981,669  1,353,702  991,790  1,006,319  3,973,461  2,360,021 








                
Gross profit 1,363,427  548,026  4,244,637  914,326  402,007  1,100,962  4,646,643  2,015,288 








        
Operating expenses:Operating expenses:        
Selling, general and administrative 2,094,036  1,079,472  4,089,951  2,151,786  2,879,021  1,614,351  6,968,972  3,766,137 
Research and development 1,452,393  644,248  2,913,008  1,093,219  1,268,468  890,299  4,181,476  1,983,518 








Total operating expenses 3,546,429  1,723,720  7,002,959  3,245,005  4,147,489  2,504,650  11,150,448  5,749,655 








                
Loss from operations (2,183,002) (1,175,694) (2,758,322) (2,330,679) (3,745,482) (1,403,688) (6,503,805) (3,734,367)








        
Other income (expense):        
Interest income 18,407  11,491  29,348  30,865  16,687  13,731  46,035  44,596 
Interest expense (130,631) (993) (142,961) (1,809) (131,904) (454) (274,865) (2,263)
Unrealized gain (loss) on derivative revaluation 682,210    (267,931)  
Unrealized gain on derivative revaluation 451,190    183,259   
Warrant impairment expense (183,259)   (183,259)  








Total other income (expense) 569,986  10,498  (381,544) 29,056  152,714  13,277  (228,830) 42,333 








                
Net loss (1,613,016) (1,165,196) (3,139,866) (2,301,623) (3,592,768) (1,390,411) (6,732,635) (3,692,034)
Dividend requirements on convertible preferred stock 1,518,651  406,846  1,796,426  700,551    387,019  1,796,426  1,087,570 








Net loss available to common stockholders$(3,131,667)$(1,572,042)$(4,936,292)$(3,002,174)$(3,592,768)$(1,777,430)$(8,529,061)$(4,779,604)








        
Net loss per share of common stock - basic and diluted$(0.15)$(0.08)$(0.24)$(0.15)$(0.17)$(0.09)$(0.41)$(0.24)




        



Average weighted number of common shares outstanding 20,665,004  19,508,387  20,234,075  19,442,192  21,328,989  19,719,657  20,599,047  19,534,343 








See accompanying notes to interim financial statements.


4


American Technology Corporation
STATEMENTS OF CASH FLOWS
(Unaudited)

For the nine months ended June 30, 

 
For the six months ended March 31,
 2005  2004  
2005
 2004
 
 
 
Increase (Decrease) in Cash          
Operating Activities:    
Net loss$(3,139,866)$(2,301,623)$(6,732,635)$(3,692,034)
Adjustments to reconcile net loss to net cash
used in operations:
    
Depreciation and amortization 212,050  106,024  320,158  164,920 
Allowance for doubtful accounts 80,000   
Warranty provision (76,723) 25,933  (16,915) 83,233 
Provision for obsolete inventory 183,535   
Options granted for compensation 270,043    329,202  150,000 
Unrealized loss on derivative revaluation 267,931   
Common stock issued for legal settlement 140,175   
Amortization of debt discount 98,793    190,530   
Provision for obsolete inventory 239,986   
    
Changes in assets and liabilities:Changes in assets and liabilities:    
Trade accounts receivable 432,244  (1,221,810) 339,439  (1,202,762)
Inventories (493,601) (215,086) (1,104,060) (488,864)
Prepaid expenses and other (29,773) (48,835) (173,157) (221,109)
Accounts payable 205,935  118,846  821,283  430,086 
Warranty payments (16,357) (20,433) (86,515) (37,588)
Accrued liabilities 317,254  (101,768) 253,942  (95,414)




Net cash used in operating activities (1,712,084) (3,658,752) (5,455,018) (4,909,532)




    
Investing Activities:Investing Activities:    
Purchase of equipment (355,995) (104,765) (448,535) (299,623)
Patent costs paid (144,420) (204,819) (187,579) (254,096)




Net cash used in investing activities (500,415) (309,584) (636,114) (553,719)




    
Financing Activities:Financing Activities:    
Offering Costs Paid (102,875)  
Payments on capital lease (6,264) (5,662) (8,122) (7,341)
Proceeds from issuance of unsecured promissory notes 2,000,000    1,979,023   
Proceeds from exercise of common stock warrants 1,661,277  50,000  1,661,277  50,000 
Proceeds from exercise of stock options 643,802  653,202  649,577  1,056,367 




Net cash provided by financing activities 4,195,940  697,540  4,281,755  1,099,026 




Net increase (decrease) in cash 1,983,441  (3,270,796)
Net decrease in cash (1,809,377) (4,364,225)
Cash, beginning of period 4,178,968  9,850,358  4,178,968  9,850,358 




Cash, end of period$6,162,409 $6,579,562 $2,369,591 $5,486,133 




    
Supplemental Disclosure of Cash Flow InformationSupplemental Disclosure of Cash Flow Information    
Cash paid for interest$1,058 $1,809 $44,443 $2,263 
Cash paid for taxes$ $ $ $ 
Non-cash financing activities:    
Warrants issued for offering costs$843,105 $ $843,105 $ 
Warrants issued for debt financing$723,000 $ $723,000 $ 
Common stock issued on conversion of Series E preferred stock$2,604,238 $320,414 
Common stock issued on conversion of Series D preferred stock$581,666 $ 
Common stock issued for legal settlement accrual$ $248,000 $ $248,000 

See accompanying notes to interim financial statements.


5


1. OPERATIONS

American Technology Corporation (the Company) is engaged in design, development and commercialization of sound, acoustic and other technologies. The Company produces products based on its HyperSonic® Sound (HSS®), Long Range Acoustic Device (LRAD™), Medium Range Acoustic Device (MRADTM), NeoPlanar® and other sound technologies.

The Company’s operations are organized into two segments by the end-user markets they serve. The Commercial Products Group, (Commercial Group), formerly known as the Business Products and Licensing Group, markets and licenses HSS and NeoPlanar products to companies that employ audio in consumer, commercial and professional applications. The Government and Force Protection Systems Group (Government Group) markets LRAD, MRAD, NeoPlanar, SoundCluster™ and HSS products to government and military customers and to the expanding force protection and commercial security markets.

The Company’s principal markets for its proprietary sound reproduction technologies and products are in North America, Europe and Asia.

The Company continues to be subject to certain risks, including history of net losses and expectation to continue to incur net losses; need for additional capital; potential dilutive impact on its stockholders of the Committed Equity Financing Facility (CEFF) described in Note 11 below; dependence on a limited number of customers; reliance on third partythird-party suppliers and manufacturers; competition; the uncertainty of the market for new sound products; limited manufacturing, marketing and sales experience; uncertainty regarding future warranty costs; and the substantial uncertainty of ability to achieve profitability and positive cash flow.

2.  STATEMENT OF PRESENTATION AND MANAGEMENT’S PLAN

The accompanying unaudited interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information. In the opinion of management, the interim financial statements reflect all adjustments of a normal recurring nature necessary for a fair presentation of the results for interim periods. Operating results for the three and sixnine months are not necessarily indicative of the results that may be expected for the year. The interim financial statements and notes thereto should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended September 30, 2004 included in the Company’s annual report on Form 10-K. Certain amounts reported in prior periods have been reclassified to be consistent with the current period presentation.

Other than cash of $6,162,409$2,369,591 at March 31,June 30, 2005, accounts receivable collections and possiblethe net proceeds fromof the CEFF describedequity financing completed in July 2005 (see Note 11 below,15 below) (the 2005 Equity Financing), the Company has no other material unused sources of liquidity at this time. The Company has financed its operations primarily through cash generated from product sales and from financing activities. Management expects to incur additional operating losses during the balance of fiscal 2005 as a result of expenditures for research and development and marketing costs for proprietary sound products.costs. The timing and amounts of these expenditures and the extent of the Company’s operating losses will depend on future product sales levels and other factors, some of which are beyond management’s control. Based on the Company’s cash position at June 30, 2005 and possiblethe proceeds fromof the CEFF,2005 Equity Financing, and assuming currently planned expenditures and level of operations, management believes the Company will have sufficient capital resources for at least the next twelve months. Management believes increased product sales will provide additional operating funds. If required, management has significant flexibility to adjust the level of research and development and selling and administrative expenses based on the availability of resources.


3.  NET LOSS PER SHARE

Basic earnings (loss) per share includes no dilution and is computed by dividing income (loss) available to common stockholders, after deduction for cumulative imputed and accreted dividends, by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per share reflects the potential dilution of securities that could share in the earnings of an entity. The Company’s losses for the periods presented cause the inclusion of potential common stock instruments outstanding to be antidilutive. Stock options and warrants exercisable into 4,437,5454,442,044 shares of common stock were outstanding at March 31,June 30, 2005 and stock options, warrants and convertible preferred stock exercisable or convertible into 4,900,8705,071,647 shares of common stock were outstanding at March 31,June 30, 2004. These securities wereare not included in the computation of diluted earnings (loss) per share because of the losses but could potentially dilute earnings (loss) per share in future periods.

6


The Company has allocated the proceeds from prior preferred stock issuances between the preferred stock and warrants and also calculated the beneficial conversion discount for each series of preferred stock. The value of the beneficial conversion discount and the value of the warrants were recorded as a deemed dividend and were accreted over the conversion period of the preferred stock. Net loss available to common stockholders was increased in each period presented in computing net loss per share by the accretion of the value of these imputed deemed dividends. Such imputed deemed dividends were not included in the Company’s stockholders’ equity as the Company has an accumulated deficit. Amounts were included in net loss available to common stockholders. The imputed deemed dividends were not contractual obligations of the Company to pay such imputed dividends. All of the Company’s outstanding shares of Series D and E Preferred Stock were converted to common stock during the quarter ending March 31, 2005.

The provisions of each of the Company’s series of preferred stock also provided for a 6% per annum accretion in the conversion value (similar to a dividend). These amounts also increased the net loss available to common stockholders. Net loss available to common stockholders is computed as follows:

Three Months Ended
March 31,
 Six Months Ended
March 31,
 Three Months Ended
June 30,
 Nine Months Ended
June 30,
 
2005 2004 2005 2004 2005 2004 2005 2004 

 
 
 
 



Net loss$(1,613,016)$(1,165,196)$(3,139,866)$(2,301,623)$(3,592,768)$(1,390,411)$(6,732,635)$(3,692,034)
Imputed deemed dividends on Series D and E
warrants issued with preferrd stock
 (490,857) (146,274) (592,137) (247,113)   (100,179) (592,137) (347,292)
Imputed deemed dividends on Series D and E
preferred stock
 (1,013,854) (214,112) (1,146,917) (359,990)   (243,396) (1,146,917) (603,386)
Accretion on preferred stock at 6% stated rate:        
Series D preferred stock (1,500) (7,500) (9,167) (15,000)   (7,500) (9,167) (22,500)
Series E preferred stock (12,440) (38,960) (48,205) (78,448)   (35,944) (48,205) (114,392)








Net loss available to common stockholders$(3,131,667)$(1,572,042)$(4,936,292)$(3,002,174)$(3,592,768)$(1,777,430)$(8,529,061)$(4,779,604)








On January 18, 2005, the Company gave notice to all holders of Series D and Series E Preferred Stock that it had elected to convert all of the outstanding shares of Series D and Series E Preferred Stock to common stock. The designations, rights and preferences of the Series D and Series E Preferred Stock permitted the Company to exercise this conversion option if the market price of its common stock exceeded $9.50 for ten consecutive trading days and certain other conditions were satisfied. The price condition was satisfied on January 6, 2005. The conversion of the Series D Preferred Stock was effective on January 18, 2005 and resulted in all 50,000 issued and outstanding shares of Series D Preferred Stock converting into an aggregate of 129,259 shares of common stock. The conversion of the Series E Preferred Stock was effective on February 1, 2005, and resulted in all 233,250 issued and outstanding shares of Series E Preferred Stock converting into an aggregate of 801,306 shares of common stock.

As all the Series D and Series E Preferred Stock waswere called for conversion as described above, $1,504,711 wasof deemed dividends were accelerated and accreted in the quarter ending March 31, 2005, in addition to the accretion of $13,940 at the stated rate of 6%, increasing the net loss available to common stockholders for that period.


7


4.  STOCK-BASED COMPENSATION

The Company accounts for employee stock-based compensation using the intrinsic value method. In most cases, the Company does not recognize compensation expense for its employee stock option grants, as they have been granted at the fair market value of the underlying Common Stockcommon stock at the grant date. Had compensation expense for the Company’s employee stock option grants been determined based on the fair value at the grant date for awards through March 31,June 30, 2005 consistent with the provisions of Statement of Financial Accounting Standards No. 123, its after-tax net income and after-tax net income per share would have been reduced to the pro forma amounts indicated below:

Three Months Ended
June 30,
 Nine Months Ended
June 30,
 
Three Months Ended
March 31,
 Six Months Ended
March 31,
 2005 2004 2005 2004 
2005
 2004
 2005
 2004
 
 
 
 
 
Net loss available to common shareholders$(3,131,667)$(1,572,042)$(4,936,292)$(3,002,174)$(3,592,768)$(1,777,430)$(8,529,061)$(4,779,604)
Plus: Stock-based employee compensation
expense included in reported net loss
     266,963    57,619    324,582   
Less: Total stock-based employee compensation expense
determined using fair value based method
 (326,524) (262,566) (884,226) (507,855) (326,240) (150,489) (1,210,466) (658,344)








Pro forma net loss available to common stockholders$(3,458,191)$(1,834,608)$(5,553,555)$(3,510,029)$(3,861,389)$(1,927,919)$(9,414,945)$(5,437,948)








Net loss per common share - basic
and diluted - as reported
$(0.15)$(0.08)$(0.24)$(0.15)$(0.17)$(0.09)$(0.41)$(0.24)








Net loss per common share - basic
and diluted - pro forma
$(0.17)$(0.09)$(0.27)$(0.18)$(0.18)$(0.10)$(0.46)$(0.28)








The Company estimates the fair value of each stock award at the grant date by using the Black-Scholes option-pricing model with the following weighted average assumptions used for grants in 2005 and 2004, respectively: dividend yield of zero percent for each period; expected volatility of 53 to 5658 percent in 2005 and 60 to 75 percent in 2004; risk-free interest rates of 3.82 to 1.84 percent; and expected lives of 2.5 years for each period. The estimated fair value of the options so determined is then amortized to expense over the options’ vesting periods.

5.  RECENT ACCOUNTING PRONOUNCEMENTS

In December 2004, the Financial Accounting Standards Board (FASB) issued Financial Accounting Standard (FAS) 123(R),123R, “Share Based Payment.”Payment” (“Statement 123R”) Although Statement 123(R)123R states that it is effective for public companies at the beginning of the first interim or annual period after June 15, 2005, the Securities and Exchange Commission has adopted a rule delaying the required compliance date to the first interim or annual reporting period of the registrant’s first fiscal year beginning on or after June 15, 2005. Therefore, the Company will first be required to comply with Statement 123(R)123R in the quarter ending December 31, 2005. This statement eliminates the ability to account for share-based compensation using the intrinsic value-based method under APB Opinion No. 25, “Accounting for Stock Issued to Employees.” Statement 123(R)123R would require the Company to calculate equity-based compensation expense for stock options and employee stock purchase plan rights granted to employees based on the fair value of the equity instrument at the time of grant. Currently, the Company discloses the pro forma net income (loss) and the related pro forma income (loss) per share information in accordance with FAS 123 and FAS 148, “Accounting for Stock-Based Compensation Costs-Transition and Disclosure.” The Company has not evaluated the impact that Statement 123(R)123R will have on its financial position and results of operations.

In November 2004, the FASB issued SFAS No. 151, “Inventory Costs an amendment of ARB 43, Chapter 4.” SFAS No. 151 clarifies that abnormal amounts of idle facility expense, freight, handling costs, and wasted materials (spoilage) should be recognized as current-period charges and requires the allocation of fixed production overheads to inventory based on the normal capacity of the production facilities. SFAS No. 151 is effective for fiscal years beginning after June 15, 2005. The Company is currently evaluating the financial statement impact of the implementation of SFAS No. 151.

8


In December 2004, the FASB issued SFAS No. 153, “Exchanges of Non-monetary Assets, an Amendment of APB Opinion No. 29”, which is effective for non-monetary exchanges occurring in fiscal periods beginning after June 15, 2005. SFAS No. 153 amends APB Opinion No. 29, “Accounting for Non-monetary Transactions” to eliminate the exception for non-monetary exchanges of similar productive assets and replaces it with a general exception for exchanges of non-monetary assets that do not have commercial substance. A non-monetary exchange has commercial substance if the future cash flows of the entity are expected to change significantly as a result of the exchange. The Company does not expect SFAS No. 153 to affect the Company’s financial condition or results of operations.

In September 2004, the Emerging Issues Task Force (EITF) reached consensus on EITF Issue 04-8, “The Effect of Contingently Convertible Debt on Diluted Earnings per Share”, which provides guidance on when the dilutive effect of contingently convertible debt securities with a market price trigger should be included in diluted earnings per share. The guidance is effective for all periods ending after December 15, 2004. The Company’s adoption of EITF 04-8 did not have an impact on the Company’s loss per share calculation for the periods presented herein and is not expected to have an impact in the future.

In March 2005, the FASB issued Interpretation No. 47 (“FIN 47”), “Accounting for Conditional Asset Retirement Obligations.” FIN 47 clarifies that an entity must record a liability for a “conditional” asset retirement obligation if the fair value of the obligation can be reasonably estimated. The provision is effective no later than the end of fiscal years ending after December 15, 2005. The Company does not expect FIN 47 to affect the Company’s financial condition or results of operations.

In May 2005, the FASB issued SFAS No. 154, “Accounting Changes and Error Corrections”, applying to all voluntary accounting principle changes as well as the accounting for and reporting of such changes. SFAS No. 154 replaces APB Opinion No. 20, “Accounting Changes”, and SFAS No. 3, “Reporting Accounting Changes in Interim Financial Statements.” SFAS No. 154 is effective for accounting changes and corrections of errors made in fiscal years beginning after December 15, 2005. The Company does not expect SFAS No. 154 to affect the Company’s financial condition or results of operations.

In March 2005, the Securities and Exchange Commission (“SEC”) issued staff accounting bulletin 107 (“SAB 107”) which expresses views of the SEC staff regarding the interaction between Statement 123R and certain SEC rules and regulations and provide the staff’s views regarding the valuation of share-based payment arrangements for public companies. SAB 107 provides guidance related to share-based payment transactions with non-employees, the transition from nonpublic to public entity status, valuation methods (including assumptions such as expected volatility and expected term), the accounting for certain redeemable financial instruments issued under share-based payment arrangements, the classification of compensation expense, non-GAAP financial measures, first-time adoption of Statement 123R in an interim period, capitalization of compensation cost related to share-based payment arrangements, the accounting for income tax effects of share-based payment arrangements upon adoption of Statement 123R, the modification of employee share options prior to adoption of Statement 123R and disclosures in Management’s Discussion and Analysis subsequent to adoption of Statement 123R. The Company has not evaluated the impact that SAB 107 will have on its financial position and results of operations.

9


6.  INVENTORIES AND CONTRACT MANUFACTURERMANUFACTURING

Inventory is stated at the lower of cost, which approximates actual costs on a first-in first-out (FIFO)standard cost basis, or market. At March 31,June 30, 2005 $597,560$104,535 of inventory value was located at the Company’s contract manufacturer in San Jose, California.manufacturer.


Inventories consisted of the following:

March 31,
2005
 September 30,
2004
 June 30,
2005
 September 30,
2004
 



 
 
Finished goods $719,057 $342,647 $901,323 $342,647 
Raw materials  535,639  418,448  963,832  418,448 




  1,254,696 761,095 1,865,155  761,095 
Reserve for obsolescence  (349,986) (110,000) (293,535) (110,000)




 $904,710 $651,095 $1,571,620 $651,095 




During the sixnine months ended March 31,June 30, 2005, the Company shipped materials to it'sits contract manufacturer, booked an amount due from the contract manufacturer and reduced inventory by $387,889.$439,312. The Company did not recognize any revenue on these transactions. At March 31,June 30, 2005, the remaining balance due from the contract manufacturer, for shipments made to it, was $160,050.$67,619. The contract manufacturer usedis using these materials to build products for the Company. The aboveamount due from the contract manufacturer of $160,050$67,619 has been netted against the payable due to the contract manufacturer.

7.  CUSTOMER CONCENTRATION

For the sixthree months ended March 31,June 30, 2005, sales to one customer in the Government Group accounted for 82%62% of total revenues. At June 30, 2005, this customer accounted for 21% of accounts receivable, net, and three other customers accounted for 30%, 21% and 14% of accounts receivable, net, respectively. No other customer accounted for more than 10% of accounts receivable, net, at June 30, 2005. For the three months ended June 30, 2004, sales to three customers in the Government Group accounted for 62%, 22% and 13% of total revenues. At June 30, 2004 the accounts receivable from these three customers accounted for 40%, 28% and 6% of accounts receivable, net, respectively and no other customer accounted for more than 10% of accounts receivable, net. For the nine months ended June 30, 2005, sales to one customer in the Government Group accounted for 79% of total revenues and sales to a second customer in the Government Group, including affiliates of the customer, accounted for 10% of total revenues. For the threenine months ended March 31, 2005, sales to one customer in the Government Group accounted for 93% of total revenues. At March 31, 2005,this customer accounted for 56% of accounts receivable, and two other customers accounted for 21% and 14% of accounts receivable. No other customer accounted for more than 10% of accounts receivable at March 31, 2005. For the six months ended March 31, 2004, sales to three customers in the Government Group accounted for 41%, 32% and 11% of total revenues respectively. For the three months ended March 31,June 30, 2004, sales to two customers in the Government Group accounted for 62%51% and 17%28% of total revenues. At March 31, 2004, the accounts receivable from these two customers accounted for 66% and 12% of accounts receivable respectively and no other customer accounted for more than 10% of accounts receivable.revenues, respectively. Management believes that the loss of any one of these significant customers would have a material adverse effect on the Company’s results of operations and financial condition.

8.  INTANGIBLES

Patents are carried at cost and, when granted, are amortized over their estimated useful lives. The carrying value of patents is periodically reviewed and impairments, if any, are recognized when the expected future benefit to be derived from an individual intangible asset is less than its carrying value. Patents consisted of the following:

March 31,
2005
 September 30,
2004
 
June 30,
 2005
 September 30,
2004
 



 
 
Cost 1,722,997 $1,578,578 $1,770,856 $1,578,578 
Accumulated amortization  (386,482) (299,871) (415,703) (299,871)



 
 
Net patent $1,336,515 $1,278,707 $1,355,153 $1,278,707 



 
 

10


9.  PRODUCT WARRANTY COST

The Company establishes a warranty reserve based on anticipated warranty claims at the time product revenue is recognized. Factors affecting warranty reserve levels include the number of units sold and anticipated cost of warranty repairs and anticipated rates of warranty claims. The Company evaluates the adequacy of the provision for warranty costs each reporting period.

Changes in the warranty reserve during the three and sixnine months ended March 31,June 30, 2005 and 2004 were as follows:

Three Months Ended
March 31,
 Six Months Ended
March 31,
 Three Months Ended
June 30,
 Nine Months Ended
June 30,
 
2005 2004 2005 2004 2005 2004 2005  2004 

 
 
 
 
 
 
 
 
Beginning balance $408,834 $315,000 $331,917 $319,500 $238,837 $325,000 $331,917 $319,500 
Warranty provision, net  (158,886) 30,433  (76,723) 25,933  59,809  57,300  (16,915) 83,233 
Warranty deductions  (11,111) (20,433) (16,357) (20,433) (70,159) (17,155) (86,515) (37,588)








Ending balance $238,837 $325,000 $238,837 $325,000 $228,487 $365,145 $228,487 $365,145 








10.  UNSECURED SUBORDINATED PROMISSORY NOTES AND RELATED PARTY TRANSACTION

In December 2004, the Company sold an aggregate of $2,000,000 of 8% unsecured subordinated promissory notes due December 31, 2006. Interest on these notes accrues at the rate of 8% per year and is due and payable quarterly in arrears. For the three and sixnine months ended March 31,June 30, 2005, wethe Company recorded interest on these notes of $39,452$39,890 and $42,959,$82,849, respectively. The Company iswas required to use 40% of the net proceeds of any future equity financing to prepay these notes, including any amountsand the Company raises pursuant to the CEFF described in Note 11 below. The Company may prepaybalance due on the notes at its discretion at any time without penalty after June 30, 2005.

and accrued interest were paid in full in July 2005 following the completion of the 2005 Equity Financing (see Note 15). In connection with the issuance of thesethe notes, the purchasers were granted warrants to purchase an aggregate of 150,000 shares of its common stock. The exercise price of the warrants was $9.28 per share for purchasers who were directors, officers, employees or consultants of the Company, or affiliates of such persons, and $8.60 per share for other purchasers. Warrants exercisable for 75,000 shares were issued at each such exercise price. The fair value of such warrants, which amounted to $723,000, and closing costs of $20,977 have beenwere recorded as debt discount to beand amortized over the term of the notes. The following variables were used to determine the fair value of the warrants under the Black-Scholes option pricing model: volatility of 56%, term of five years, risk free interest of 2.97% and underlying stock price equal to fair market value at the time of grant. For the three and sixnine months ended March 31,June 30, 2005, $90,734$91,737 and $98,793,$190,530, respectively, of debt discount was amortized.

A trust affiliated with an officer, director and significant stockholder of the Company purchased one of the aforementioned promissory notes in the principal amount of $500,000 and received a warrant exercisable for 37,500 shares with an exercise price of $9.28 per share.

1011


11.  STOCKHOLDERS’ EQUITY

Summary

The following table summarizes changes in equity components from transactions during the sixnine months ended March 31,June 30, 2005:

    Additional
Paid-in
Capital
 Accumulated
Deficit
 Total
Stockholders’
Equity
(Deficit)
 
   Preferred Stock    Common Stock 
Shares AmountShares Amount
Preferred Stock 
 
Common Stock 
 
 Additional
Paid-in
  
Accumulated 
  
Total
Stockholders’
Equity
 







Shares
 
Amount 
 
Shares
  
Amount
 
Capital
 
 Deficit
 
 (Deficit) 
 
Balance, October 1, 2004  283,250 $3  19,808,819 $198 $47,520,207 $(42,327,493)$5,192,915 283,250 $3  19,808,819 $198 $47,520,207 $(42,327,493)$5,192,915 
Stock issued upon exercise of 369,568
warrants
      369,568  4  1,661,273    1,661,277     369,568  4  1,661,273    1,661,277 
Conversion of Series D Preferred Stock  (50,000) (1) 129,259  1       (50,000) (1) 129,259  1       
Conversion of Series E Preferred Stock  (233,250) (2) 801,306  8  (6)    (233,250) (2) 801,306  8  (6)    
Cashless exercise of 25,000 Warrants      20,425             20,425         
Stock issued upon exercise of stock options      187,862  2  643,800    643,802     189,612  2  649,575    649,577 
Value assigned to extension of time to
exercise 92,675 options
          266,963    266,963         324,582    324,582 
Debt discount for 150,000 warrants granted
on 8% unsecured subordinated promissory notes
          723,000    723,000         723,000    723,000 
Issuance of stock options and warrants for
services
          3,080    3,080         4,620    4,620 
Issuance of common stock for legal settlement    17,500    140,175    140,175 
Deemed dividends and accretion on
convertible preferred stock of $1,796,426
                            
Net loss for the period            (3,139,866) (3,139,866)          (6,732,635) (6,732,635)








 
 
 
 
 
 
 
Balance, March 31, 2005   $  21,317,239 $213 $50,818,317 $(45,467,359)$5,351,171 
Balance, June 30, 2005 $  21,336,489 $213 $51,023,426 $(49,060,128)$1,963,511 








 
 
 
 
 
 
 

As ofDuring the quarter ended March 31, 2005, all previously outstanding shares of Series D and Series E Preferred Stock were converted into an aggregate of 930,565 shares of common stock.stock and no preferred stock was outstanding at June 30, 2005.

Committed Equity Financing Facility

In December 2004, the Company entered into a $25 millioncommon stock purchase agreement, registration rights agreement and warrant as part of a Committed Equity Financing Facility (CEFF) with Kingsbridge Capital Limited, a firm specializing in financing smallLtd., pursuant to medium sized technology-based companies. The CEFF allows the Companywhich Kingsbridge committed to sellpurchase up to Kingsbridge, subject to certain significant limiting conditions, a maximum of 3,684,782 shares of its common stock at a price between 88% and 92%$25 million of the volume weighted average price during 15 day purchase periods.

Company’s common stock. As part of the arrangement, the Company issued a warrant to Kingsbridge to purchase 275,000 shares of its common stock at a price of $8.60 per share. The warrant iswas exercisable beginning six months after the date of issuancegrant and for a period of five years thereafter. The Company also agreedSubject to filecertain conditions, including the effectiveness of a registration statement forregistering the resaleshares issuable to Kingsbridge, the Company had the right to require Kingsbridge to purchase a maximum of 3,684,782 newly-issued shares acquired under the CEFF, or upon exerciseof its common stock at a price between 88% and 92% of the warrant, within 45 days after entering into the agreement for the CEFF. In January 2005 the Company filed the required resale registration statement. The registration statement has not yet been declared effective.volume weighted average price during a 15 day purchase period. The 3,684,782 share maximum also includesincluded any shares that the Company may issuehave issued in lieu of paying Kingsbridge liquidated damages in the event that a registration statement iswas unavailable for the resale of the securities purchased by Kingsbridge under the CEFF once the registration statement hashad been declared effective. The Company hashad no obligation to draw down all or any portion of the commitment during its 24-month term.

The Company is obligated to use 40%As part of the proceeds it may receive fromarrangement, the CEFF or other equity financingsCompany also agreed to prepay any outstanding interest and principal on the notes described in Note 10 above. The Company may also be required to pay liquidated damages of up to $2,500,000 in the event thatfile a registration statement, is not availablewithin 45 days after entering into the agreement for the CEFF, for the resale of securities purchased byshares to be acquired under the CEFF, or upon exercise of the warrant. In January 2005, the Company filed the required resale registration statement. In June 2005, the Company decided to terminate the CEFF; and on July 1, 2005, the Company requested withdrawal of the registration statement.

12


In July 2005, the Company entered into a termination, settlement and release agreement with Kingsbridge. Under the terms of this agreement, the Company and Kingsbridge agreed that the common stock purchase agreement entered into with Kingsbridge in December 2004, and the related registration rights agreement and warrant issued to Kingsbridge of the same date would be terminated, and Kingsbridge would return the warrant, which was not exercised, to the Company for cancellation. No shares were sold to Kingsbridge under the CEFF.CEFF prior to the termination. The Company has also agreed to pay toincurred no early termination penalties in connection with this termination. The termination agreement contains a consultant, who is not an affiliatemutual release of the Company or Kingsbridge, a finder fee equal to 4% of the first $5 million raised under the CEFF, 3% for the second $5 million raised under the CEFF, 2% for the third $5 million raised under the CEFF, and 1.5% for any additional amounts raised.claims.


The fair value of the warrant at the date of issuance, which amounted to $843,105, and legal, audit and associated fees of $193,079$293,826, were recorded as prepaid transaction costs. These costs will be reclassified to equity once the registration statement is declared effective or upon exercise of the warrant. The following variables were used to determine the fair value of the warrant under the Black-Scholes option pricing model: volatility of 56%, term of 5.5 years, risk free interest of 2.97% and underlying stock price equal to fair market value at the time of issuance. The warrant has been accounted for as a derivative instrument in accordance with Emerging Issues Task Force (EITF) 00-19 “Accounting for Derivative Financial Instruments, Indexed to, and Potentially Settled in a Company’s Own Stock.” As a derivative, the fair value of the warrant is recorded as a liability at its estimated fair value at each balance sheet date until the effective date of the related registration statement, or upon warrant exercise, when the warrant liability, as may be further revalued, will bewould have been reclassified to equity. Changes in the fair value of the warrant are recorded as other income or expense in the accompanying income statement. For the three and nine months ended March 31,June 30, 2005, $682,210$451,190 and $183,259, respectively, was recorded as unrealized gain for the change in valuation of the fair value of the warrant. For the period measured from the issuance date of December 14, 2004 until March 31, 2005, $267,931 was recorded as an unrealized expenseon derivative revaluation for the change in valuation of the fair value of the warrant.

Due to the decision to terminate this financing, the Company determined that the value of the prepaid transaction cost asset was impaired at June 30, 2005. Accordingly, the Company recognized an impairment charge in the total amount of $477,085, of which $293,826 is legal, audit and associated fees and is recorded as selling, general and administrative expense for the three and nine months ended June 30, 2005, and $183,259,is the excess of the fair value of the warrant over the associated derivative instrument liability and is recorded as warrant impairment expense for the three and nine months ended June 30, 2005. The remaining asset of $659,846 in prepaid transaction costs will be offset against the derivative instrument liability of the same amount during the quarter ending September 30, 2005, with no net effect on other income or expense.

Stock Options

During the sixnine months ended March 31,June 30, 2005, the Company recorded non-cash compensation expense of $266,963 for the extension of time to exercise stock options for former employees relating to an aggregate of 92,675 shares of common stock.stock and $57,619 for option expense relating to options for 68,125 shares held by an officer of the Company who transitioned from employee to consultant. For the three and sixnine months ended March 31,June 30, 2005, the Company also recognized $1,540 and $3,080$4,620 of non-cash compensation expense, respectively, for the value of options granted to non-employees. These options were valued in the same manner as described in Note 4 for employee options. There were no non-cash compensation expenses for the quarter ended March 31,June 30, 2004 or for the sixnine months ended March 31,June 30, 2004.

The following table summarizes information about stock option activity during the sixnine months ended March 31,June 30, 2005:

Number of
Options
 Weighted Average
exercise price
 
 
 
 
Outstanding October 1, 2004  1,839,498 $4.68 
     Granted  597,500 $8.28 
     Exercised  (187,862)$(3.43)
     Canceled/expired  (119,825)$(4.62)
 
 
 
Outstanding March 31, 2005  2,129,311 $5.80 
 
 
 
Exercisable March 31, 2005  886,902 $3.98 
 
 
 
 Options 
 
 
 
Number of
Shares 
 
Weighted Average
Exercise Price 
 
Outstanding October 1, 2004 1,839,498 $4.68 
    Granted 797,500 $7.63 
    Exercised (189,612)$(3.43)
    Canceled/expired (313,576)$(6.26)
 
 
 
Outstanding June 30, 2005 2,133,810 $5.53 
 
 
 
Exercisable June 30, 2005 1,000,240 $4.26 
 
 
 

Options outstanding are exercisable at prices ranging from $2.50 to $10.06 and expire over the period from 2005 to 2010 with an average life of 3.1 years.

13


Stock Purchase Warrants

The following table summarizes information about warrant activity during the sixnine months ended March 31,June 30, 2005:

Number of
Warrants
 Weighted Average
Exercise Price
 
Warrants
 
 

 
 Number of
Shares
 Weighted Average
Exercise Price
 
Outstanding October 1, 2004  2,352,802 $3.74  2,352,802 $3.74 
Issued  425,000 $8.72  425,000 $8.72 
Exercised  (394,568)$( 4.34) (394,568)$(4.34)
Canceled/expired  (75,000)$(11.00) (75,000)$(11.00)

 
 
 
 
Outstanding March 31, 2005  2,308,234 $4.31 
Outstanding June 30, 2005 2,308,234 $4.32 

 
 
 
 

At March 31,June 30, 2005, the following stock purchase warrants were outstanding arising from offerings and other transactions, eachtransactions:

Number of
Shares 
 
Exercise
Price
 
Expiration
Date 
     
655,000 $          2.00 September 30, 2006
451,880 $          3.01 March 31, 2007
272,729 $          6.75 July 10, 2007
100,000 $          4.25 September 30, 2007
353,625 $          3.25 December 31, 2007
50,000 $          3.63 April 8, 2008
75,000 $          8.60 December 31, 2009
75,000 $          9.28 December 31, 2009
275,000 $          8.60 June 14, 2010
   
2,308,234    

As a result of the termination of the Kingsbridge Agreement (see Committed Equity Financing Facility section above), the warrant for 275,000 shares which was exercisable into one common share:until June 14, 2010 at $8.60 per share was cancelled on July 11, 2005.

12


Number Exercise
Price
 Expiration
Date

 
 
            
655,000  $2.00  September 30, 2006
451,880  $3.01  March 31, 2007
272,729  $6.75  July 10, 2007
100,000  $4.25  September 30, 2007
353,625  $3.25  December 31, 2007
50,000  $3.63  April 8, 2008
75,000  $8.60  December 31, 2009
75,000  $9.28  December 31, 2009
275,000  $8.60  June 14, 2010

          
2,308,234          

          
The warrants exercisable for 272,729 shares which expire on July 10, 2007 contain anti-dilution provisions, and as a result of the 2005 Equity Financing (see Note 15 below) the exercise price of those warrants will adjust from $6.75 to $6.55 at the option of the holders.

12.  BUSINESS SEGMENT DATA

The Company is engaged in design, development and commercialization of sound, acoustic and other technologies. The Company’s operations are organized into two segments by the end-user markets they serve. The Company’s reportable segments are strategic business units that sell the Company’s products to distinct distribution channels. The Commercial Products Group (Commercial Group) markets and licenses HSS, NeoPlanar and NeoPlanarother sound products incorporating the Company’s technologies to companies that employ audio in consumer, commercial and professional applications. The Government and Force Protection Systems Group (Government Group) markets LRAD, MRAD, NeoPlanar, Sound Cluster and HSS sound products to government and military customers and to the expanding force protection and commercial security markets. The segments are managed separately because each segment requires different selling and marketing strategies as the class of customers within each segment is different.

The accounting policies of the segments are the same as those described in the summary of significant accounting policies. The Company does not allocate operating expenses or assets between its two reportable segments. Accordingly the measure of profit for each reportable segment is gross profit.

  Three Months Ended
March 31,
  Six Months Ended
March 31,
  
  2005  2004  2005  2004  
  
  
  
  
  
Revenues:                
  Commercial Products Group$109,523  $455,156  $296,872  $537,095  
  Government Group  2,707,870    1,038,094    6,929,434    1,730,933  
  
  
  
  
  
  $2,817,393  $1,493,250  $7,226,306  $2,268,028  
  
  
  
  
  

Three Months Ended
March 31,
  Six Months Ended
March 31,
  Three Months Ended
June 30,
 Nine Months Ended
June 30,
 
2005  2004  2005  2004  20052004 2005 2004 





 
 
 
 
Gross Profit (Loss):                
Revenues:            
Commercial Products Group$(408,137)$(73,180)$(612,433)$(76,792)$172,687 $270,494 $469,560 $807,589 
Government Group  1,771,564    621,206    4,857,070    991,118   1,221,110  1,836,787  8,150,544  3,567,720 

  
  
  
  



$1,363,427  $548,026  $4,244,637  $914,326  $1,393,797 $2,107,281 $8,620,104 $4,375,309 

  
  
  
  




 Three Months Ended
June 30,
 Nine Months Ended
June 30,
 
 2005 2004 2005 2004 
 
 
 
 
 
Gross Profit (Loss):            
  Commercial Products Group$(91,184)$(167,833)$(703,617)$(244,625)
  Government Group 493,191  1,268,795  5,350,260  2,259,913 




 $402,007 $1,100,962 $4,646,643 $2,015,288 




13.  LEGAL PROCEEDINGS

In September 2003, the Company filed a complaint against eSoundIdeas, Inc., in the Superior Court of California, County of San Diego, alleging breach of contract and seeking a declaratory judgment to the effect that a License, Purchase and Marketing Agreement dated September 28, 2000 (the “ESI License Agreement”) with eSoundIdeas, a California partnership, was properly terminated in May 2003. The principals of eSoundIdeas are Greg O. Endsley and Douglas J. Paschall. The principals also founded a corporation, eSoundIdeas, Inc., which purported to assume the contractual obligations of eSoundIdeas. The Company amended the complaint in November 2003 to include eSoundIdeas (the general partnership), Mr. Endsley and Mr. Paschall as defendants. For convenience, the following discussion refers to eSoundIdeas and eSoundIdeas, Inc. collectively as “ESI.” In November 2003, the Company filed complaints in the Superior Court of California, County of San Diego, against Mr. Endsley and Paschall seeking declaratory judgments that options granted to each of Mr. Endsley and Mr. Paschall in April 2001 were terminated in October 2002.

The three cases were consolidated upon motion by the defendants and order of the court. The defendants filed a cross-action in the consolidated action alleging fraud, breach of contract in connection with the ESI License Agreement and the options, breach of the implied covenant of good faith and fair dealing, intentional interference with contract, negligent interference with contract, intentional interference with prospective economic advantage, negligent interference with prospective economic advantage, defamation, and violation of California Business and Professions Code §17200. The Company filed its answer to the second amended cross-complaint in August 2004.

In April 2005, the Company, ESI and its two principals entered into a Settlement Agreement and Mutual Release. As part of the settlement, the Company agreed to pay $150,000, which was previously accrued and recorded as a general and administrative expense, and to issue 17,500 shares of common stock to ESI, for which theESI. The fair market value of these as of April 27, 2005 wasof $140,175 which was recorded in the quarter ended March 31, 2005 as a general and administrative expense. In addition, Mr. Endsley and Mr. Paschall will be entitled to receive an aggregate commission equal to 1% of net sales from April 1, 2005 to September 28, 2007, of the Company’s HSS products specifically targeted for use in North America in the point of sale/purchase, kiosk, display, event, trade show and exhibit markets, subject to a maximum aggregate commission of $500,000. The Company also granted the recipients of the shares “piggyback” rights to have their shares included on future registration statements that the Company might file.

The Company may at times be involved in litigation in the ordinary course of business. The Company will also, from time to time, when appropriate in management’s estimation, record adequate reserves in the Company’s financial statements for pending litigation. Except as set forth above, there are no pending material legal proceedings to which the Company is a party or to which any of its property is subject.

14.  INCOME TAXES

At March 31,June 30, 2005, a valuation allowance has been provided to offset the net deferred tax asset as management has determined that it is more likely than not that the deferred tax asset will not be realized. At September 30, 2004 the Company had for federal income tax purposes net operating loss carryforwards of approximately $37,400,000, which expire through 2025 of which certain amounts are subject to significant limitations under the Internal Revenue Code of 1986, as amended.

15.SUBSEQUENT EVENTS

On July 18, 2005, the Company sold 2,868,851 shares of common stock at a purchase price of $4.88 per share (the 2005 Equity Financing). The Company also issued warrants in two series to the investors to purchase 1,581,919 shares of common stock. The “A” Warrants are exercisable for an aggregate of 717,213 shares of common stock at an exercise price of $6.36 per share until July 18, 2009. The “B” Warrants are exercisable for an aggregate of 864,706 shares of common stock at an exercise price of $7.23 per share and are exercisable from the date the registration statement referred to below becomes effective until the date six months after that effective date.


The gross proceeds from this financing were approximately $14 million. The Company incurred financing and closing costs of approximately $740,000. The Company used approximately $2.0 million of the gross proceeds to discharge the principal balance of and accrued interest on the 8% unsecured subordinated promissory notes due December 31, 2006 (see Note 10). The Company entered into a registration rights agreement with the investors, and agreed to prepare and file, within 30 days following the issuance of the securities, a registration statement covering the resale of the shares of common stock sold and the common stock issuable upon the exercise of the warrants. Failure to have an effective registration statement within 90 days obligates the Company to pay liquidated damages to the purchasers in the amount of 0.5% of the gross proceeds per month until 180 days after the closing and 1% of the gross proceeds per month thereafter.

The Company has also agreed to submit the financing to a vote of its stockholders for approval prior to June 2006. The Company further agreed that, subject to certain exceptions, if during the next year it sells shares of its common stock, or options or warrants to purchase shares of its common stock, in a private placement or in a public offering using a Form S-3, the purchasers will have certain rights of first refusal to participate in the financing. The Company has also agreed to indemnify the purchasers for certain losses.

The “A” Warrants and “B” Warrants contain provisions that would adjust the exercise price, and in inverse proportion adjust the number of shares subject to the warrant, in the event the Company pays or effects stock dividends or splits, or in the event the Company sells shares of its common stock at a purchase price, or options or warrants to purchase shares of its common stock having an exercise price, less than the exercise price of the applicable warrant. The “A” Warrants also feature a net exercise provision, which enables the holder to choose to exercise the warrant without paying cash by surrendering shares subject to the warrant with a market value equal to the exercise price. This right is available only if a registration statement covering the shares subject to the “A” Warrants is not available after it is initially declared effective. The Company has the right to redeem the “B” Warrants if the closing price of the shares of its common stock is $10.00 or greater for 15 consecutive trading days and the holder does not exercise within 20 days after the Company gives notice of redemption.

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion should be read in conjunction with the accompanying unaudited interim financial statements and the related notes included under Item 1 of this Quarterly Report on Form 10-Q, together with Management’s Discussion and Analysis of Financial Condition and Results of Operations included in the Company’s Annual Report on Form 10-K for the year ended September 30, 2004.

The following discussion provides an overview of our results of operations for the three and sixnine months ended March 31,June 30, 2005 and 2004. Significant period-to-period variances in the statements of operations are discussed under the caption “Results of Operations.” Our financial condition and cash flows are discussed under the caption “Liquidity and Capital Resources.”


Forward Looking Statements

This report contains certain statements of a forward-looking nature relating to future events or future performance. Words such as  “expects,“anticipates,”“intends,”“plans,”“believes,”“seeks,”“estimates and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the only means of identifying forward-looking statements. Prospective investors are cautioned that such statements are only predictions and that actual events or results may differ materially. In evaluating such statements, prospective investors should specifically consider various factors identified in this report, including the matters set forth below under the captionBusiness Risks, which could cause actual results to differ materially from those indicated by such forward-looking statements.

16


Overview

We are an innovator of proprietary sound reproduction technologies and products. We believe our innovative proprietary sound technologies provide us a significant competitive advantage in our principal markets. We believe we are the leader in developing and commercializing parametric loudspeakers, branded as HyperSonic® soundSound or HSS®. We believe we are also the leader in developing and commercializing high intensity directed acoustical devices, branded as our Long Range Acoustic Device or LRAD™ and Medium Range Acoustic Device or MRAD™. We have filedmore than 55 patents issued world-wide covering our various sound technologies, of which over 7045 are patents issued in the United States. We also have over 265 pending patent applications world-wide, of which over 110 are pending patent applications in the United States, and over 90 patent applications internationally covering our various sound technologies and products.States.

We make significant investments in research and development to expand our technology and product portfolio. We are expandinghave recently expanded our LRADacoustic device product family by (a) introducing a new force protection product, the MRAD, a smaller and more portable product that complements our existing LRAD device; (b) introducing and signing the first license agreement for our new SoundVector scaleable, directional sound product; and (c) introducing a new NeoPlanar product line for emergency notification and general announcementannouncing markets whichthat require high intelligibility, andintelligibility. In our fiscal quarter ending September 30, 2005, we expect to begin deliveries of the H450, our latest generation HSS product model employing a new plastic emitter. The H450 provides improved performance over our previous models at approximately half the cost. We are utilizing our technologies and products to provide solutions for difficult acoustic challenges. We offer our products for sale worldwide, but expect our largest markets to be the United States, Europe and Asia.

OurThe four major products from our technology portfolio are listed below.

 •

Our HyperSonic sound, or HSS, technology is a new parametric speaker technology that creates sound “in the air.” Sound is generated along an air column using ultrasonic frequencies, which are those above the normal range of hearing. The HSS sound beam is highly directional and maintains sound volume over longer distances than traditional loudspeakers. We believe our substantial intellectual property portfolio and pioneering HSS products support our leadership position in the field of parametric non-linear acoustics for sound reproduction, as we continue to improve and release higher reliability, lower distortion and higher output level models of our HSS products.

  

 •

Our Long Range Acoustic Device, or LRAD and MRAD products incorporate technology which produces variable intensity acoustical sound intended for use in long-range and medium-range delivery of directional sound information, which is effectively a supercharged megaphone. Both LRAD and MRAD products are designed and used as directed long-range hailing and warning systems by both government and commercial customers. We believe our LRAD and MRAD product innovation, our growing engineering capabilities, and our manufacturing and marketing competencies have established us as the leader in this new marketplace. We are marketing LRADthese products throughout the U.S. Department of Defense as “The Sound of Force Protection™”, and ourexpanding target markets are expanding to include law enforcement and commercial customers with significant security concerns. In fiscal 2004, we developed a remote controlled pan/tilt version of LRAD for critical infrastructure force protection applications, and we demonstrated our competency to engineer additional new sound solutions for the U.S. Department of Defense. We plan to introduce inIn 2005, we introduced the summer of 2005 a new Medium Range Acoustic Device (MRADTM).MRAD. MRAD will beis about half the size and weight of LRAD, and provideprovides effective hailing and warning at approximately half the range of LRAD. The portable MRAD is expected to be particularly effective on armored vehicles for urban warfare, shorter-range checkpoints and access denial, plus multiple applications for local, national and international law enforcement.

  

 •

Our NeoPlanar® technology is a thin film magnetic speaker that produces sound of high quality, low distortion and high volume. NeoPlanar applications include high-end sound, emergency notification and public address systems. In fiscal 2004, we began marketing NeoPlanar for use in large indoor spaces and in outdoor environments for emergency notification. NeoPlanar offers customers a new capability by delivering remarkably intelligible communications in difficult spaces such as aircraft hangar bays and at distances up to one-half mile.

• Our SoundCluster™ technology is a new multi-element speaker cluster optimized for even sound coverage over large areas. Our SoundCluster product offers an improved level of intelligibility and clarity in high ambient noise environments. The SoundCluster satisfies flight deck safety and large area emergency notification requirements. The flexible and ruggedized SoundCluster design lends itself to installation in harsh environments, where conventional speakers may fail. During fiscal 2004, we deployed the first SoundCluster for use on a U.S. naval warship.

1517


Our SoundCluster™ technology is a new multi-element speaker cluster optimized for even sound coverage over large areas. Our SoundCluster product offers an improved level of intelligibility and clarity in high ambient noise environments. The SoundCluster satisfies flight deck safety and large area emergency notification requirements. The flexible and ruggedized SoundCluster design lends itself to installation in harsh environments, where conventional speakers may fail. During fiscal 2004, we deployed the first SoundCluster for use on a U.S. naval warship.

We believe we are uniquely equipped to provide our technologies and products in rapidly growing markets for new sound applications not currently served by conventional sound devices and as an alternative to conventional loudspeakers. We believe market factors such as the rapid growth of plasma and flat panel screens offer significant growth opportunities for our HSS focused sound solutions. We also believe that the growth in defense and homeland security and related protection spending by commercial customers provides a growing market for our sound products to be used for intelligible communication over long distances.

Our primary products sold to date have been LRAD and HSS products. TheseDuring the nine months ended June 30, 2005, these products are currentlywere manufactured for us by Pemstar, Inc., an established contract manufacturer with multiple locations worldwide. However, during the quarter ended June 30, 2005, we terminated the relationship with Pemstar, and starting in our fiscal fourth quarter expect to start manufacturing our products at a new contract manufacturer.

Our sales have been highly dependent on large orders from a fewsmall number of customers. We target our products for sale worldwide, but expect the largest markets to be the U.S., Europe and Asia. To date, our sales have been made in U.S. Dollarsdollars and we do not expect currency fluctuations to have a material impact on our operations.

Overall Performance

Our secondFor our third fiscal quarter ended March 31,June 30, 2005, showed a substantial increase in revenues overwere 34% lower than the same period in the prior fiscal year. However, dueyear primarily as a result of reduced LRAD deliveries to significant increases in operatinggovernment customers. Operating expenses for the third fiscal quarter were 66% higher than the comparable prior year period, and as a result, our net loss for the fiscal quarter ended March 31,June 30, 2005, was 158% higher than for the same period in thecomparable prior fiscal year.year period. Our revenues for the three months ended March 31,June 30, 2005 were $2,817,393,$1,393,797, compared to $1,493,250$2,107,281 for the three months ended March 31, 2004, an increase of 89%.June 30, 2004. Our gross profit for the three months ended March 31,June 30, 2005 was 48%29% of revenues, compared to 37%52% of revenues for the comparable period in the prior fiscal year. We recorded a gross profit of $1,363,427$402,007 for the three months ended March 31,June 30, 2005, which was higher$698,955 lower than the gross profit of $548,026$1,100,962 for the three months ended March 31,June 30, 2004. Operating expenses increased from $1,723,720$2,504,650 for the three months ended March 31,June 30, 2004 to $3,546,429$4,147,489 for the three months ended March 31,June 30, 2005. In addition, for the three months ended March 31,June 30, 2005, there was a non-cash gain on derivative revaluation$115,217 of $682,210net interest expense associated with the decreasesubordinated notes sold in value of the warrant we issued to Kingsbridge Capital, and for the six months ended March 31, 2005 there was a non-cash expense of $267,931 associated with the increase in value of the same warrant. There were no corresponding entries for the same periods in the prior fiscal year.December 2004. Our net loss increased from $1,165,196$1,390,411 for the three months ended March 31,June 30, 2004 to $1,613,016$3,592,768 for the three months ended March 31,June 30, 2005.

We are continuingAs a result of our performance for the quarter and the substantial completion of major development projects such as MRAD, HSS 450 and SoundVector, we initiated an effort to reduce expenses while we continue to focus our efforts on near-term revenue and gross margin improvement from our existing, marketable products. We have filled key managementAs a result we decreased our headcount from 71 employees at March 31, 2005, to 46 employees as of June 30, 2005. The majority of the reductions were in research and operations positionsdevelopment. At June 30, 2005, 9 employees were in research and increased personneldevelopment, 13 were in ourproduction, quality assurance and materials control, 11 were in general and administrative and 13 were in marketing, sales and marketing and engineering departments. While new hires have necessarily resulted in increased expenses, we believe these new hires are important to near-term revenue and gross margin improvements. We are currently focusing our resources primarily on sales, marketing, engineering and production of existing products.licensing. We are closely monitoring expenses for all of our Advanced Development department, charged with development of new products.departments. Our policy is to establish a compelling business case for each Advanced Development initiative.all initiatives.

Our various technologies are high risk in nature. Our future is largely dependent upon the success of our sound technologies. We invest significant funds in research and development, marketing and sales and on patent applications related to our proprietary technologies. Unanticipated technical or manufacturing obstacles can arise at any time and disrupt sales or licensing activities and result in lengthy and costly delays. See “Business Risks” below.


18


Recent Developments

In April 2005, we entered into a Settlement Agreement and Mutual Release with eSoundIdeas, Inc., its two principals and a related partnership, which we refer to collectively as the ESI Parties. Pursuant to the Settlement Agreement, we and the ESI Parties settled litigation arising out of a dispute regarding a license and marketing agreement that we terminated in May 2003, and regarding stock options issued to each of the principals in April 2001 which expired unexercised following termination of consulting services provided to us by these principals. As part of the settlement, the Company agreed to pay $150,000, which was previously recorded as a general and administrative expense, and to issue 17,500 shares of common stock to the ESI Parties, for which the fair market value as of April 27, 2005 was $140,175, which was recorded in the quarter ended March 31, 2005 as a general and administrative expense. We granted the recipients of these shares “piggyback” rights to have their shares included on future registration statements that we might file. In addition, the ESI Parties will be entitled to receive an aggregate commission equal to 1% of net sales from April 1, 2005 to September 28, 2007, of our HSS products specifically targeted for use in North America in the point of sale/purchase, kiosk, display, event, trade show and exhibit markets, subject to a maximum aggregate commission of $500,000. We and the ESI Parties have executed a mutual release of claims, and have agreed to dismiss with prejudice the pending litigation among us.

In May 2005, Carl Gruenler, Vice President, Government and Force Protection Systems Group, left our company. Kalani Jones, President and Chief Operating Officer, will assumeassumed Mr. Gruenler's dutiesGruenler’s duties. In July 2005, A.J. Ballard was appointed as Senior Director of the Government and Force Protection Systems Group, reporting to Kalani Jones.

In June 2005 we entered into a design and manufacturing licensing agreement with ECCO Group (ECCO), the world’s largest manufacturer of backup alarms for commercial vehicles. The agreement covers the initial licensing and product development of our SoundVector technology to ECCO and its affiliates for backup vehicle alarms and similar uses. The agreement includes technology transfer, product development assistance and upfront licensing fees, with royalties payable, based on unit volume production. The agreement is renewable on an annual basis after an initial three-year term, with further fees due upon each renewal.

In July 2005 we entered into an agreement to terminate the Committed Equity Financing Facility with Kingsbridge Capital Limited entered into in December 2004. The termination agreement resulted from our determination that the interim untilcommon stock purchase agreement was no longer consistent with our financing plans.

In July 2005 we locate a replacementcompleted an institutional financing providing gross proceeds of $14 million. After paying financing and closing costs and retiring approximately $2 million of unsecured subordinated promissory notes, we expect to use the net proceeds for Mr. Gruenler.marketing, sales and deliveries of our proprietary directed sound products and for general working capital.

Critical Accounting Policies

We have identified the policies below as critical to our business operations and the understandings of our results of operations. Our accounting policies are more fully described in our financial statements located in Item 1 of Part I, “Financial Statements.”

The methods, estimates and judgments we use in applying our accounting policies, in conformity with generally accepted accounting principles in the United States, have a significant impact on the results we report in our financial statements. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. The estimates affect the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions. We believe that the following discussion addresses our most critical accounting policies, which are those that are most important to the portrayal of our financial condition and results of operations and require our most difficult, subjective, and complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain.

Revenue Recognition.  We currently derive our revenue primarily from two sources: (i) component and product sale revenues and associated engineering and installation, which we refer to collectively as Product Sales and (ii) contract and license fee revenue. Product Sales revenues are recognized in the periods that products are shipped to customers, FOB shipping point or destination, when a signed contract exists, the fee is fixed and determinable, collection of resulting receivables is probable and there are no remaining obligations. Revenues from engineering contracts are recognized based on milestones or completion of the contracted services. Revenues from ongoing per unit license fees are earned based on units shipped incorporating our patented proprietary technologies and are recognized in the period when the ultimate customer accepts the product and collectibility is reasonably assured. Revenues from up-front license and other fees and annual license fees are generally recognized ratably over the specified term of the particular license or agreement.

Valuation of Intangible Assets.  Intangible assets include purchased technology and patents, which are amortized over their estimated useful lives. We must make judgments and estimates regarding the future utility and carrying value of intangible assets. The carrying values of such assets are periodically reviewed and impairments, if any, are recognized when the expected future benefit to be derived from an individual intangible asset is less than its carrying value. In fiscal 2004, we reviewed the carrying value of our intangible assets and reduced the carrying value of these assets by $37,798. Our judgments and estimates regarding carrying value and impairment of intangible assets have an impact on our financial statements.


19


Warranty Reserve.  We establish a warranty reserve based on anticipated warranty claims at the time product revenue is recognized. These warranties require us to make estimates regarding the amount and costs of warranty repairs we expect to make over a period of time. Factors affecting warranty reserve levels include the number of units sold and anticipated cost of warranty repairs and anticipated rates of warranty claims. We evaluate the adequacy of the provision for warranty costs each reporting period. See Note 9 to our financial statements for additional information regarding warranties. The estimates we use have an impact on our financial statements. In the three and sixnine months ended March 31,June 30, 2005, we recorded a net warranty reduction of $158,886$10,350 and $76,723,$103,430, respectively, as a result of the following: 1)(a) we reduced the warranty reserve that we had previously established in fiscal 2003 for HSS Generation 1 products, primarily as a result of the expiration of time to return failedthe warranty period for HSS Generation 1 product to the company for replacement,products sold, and 2)(b) we recorded a warranty provision for current sales of all products.sales.

Derivative Instruments.We account for the warrant issued in December 2004 in conjunction with the Committed Equity Financing Facility with Kingsbridge Capital Limited as a derivative financial instrument. As a derivative, the fair value of the warrant is recorded as a liability in the balance sheet and changes in the fair value of the warrant are recognized as other income or expense during each period. The fair value of the warrant is expected to change primarily in response to changes in our stock price.

Significant increases in the fair value of our stock could give rise to significant expense in the period of the change. Likewise, a reduction in our stock price could give rise to significant income in the period of the change. The warrant liability will be reclassified to equity as of the effective date of the related registration statement, or upon the exercise of the warrant.

Guarantees and Indemnifications. Under our bylaws, we have agreed to indemnify our officers and directors for certain events. We also enter into certain indemnification agreements in the normal course of our business. We have no liabilities recorded for such indemnities.

Deferred Tax Asset.We have provided a full valuation reserve related to our substantial deferred tax asset as management has not determined that it is more likely than not that the deferred tax asset will not be realized. In the future, if sufficient evidence of our ability to generate sufficient future taxable income in certain tax jurisdictions becomes apparent, we may be required to reduce our valuation allowances, resulting in income tax benefits in our consolidated statement of operations. We evaluate the realizability of the deferred tax assets and assess the need for valuation allowance quarterly. The utilization of the net operating loss carryforwards could be substantially limited due to restrictions imposed under federal and state laws upon a change in ownership. Congress passed the American Jobs Creation Act of 2004 in October 2004. The new law contains numerous changes to existing tax laws, including both domestic and foreign tax incentives. We have not yet determined what impact, if any, this new law may have on our deferred tax asset, or our future results of operations and financial condition.

Legal Proceedings. We are currently involved in certain legal proceedings. We estimate the range of liability relating to pending litigation, where the amount and range of loss can be estimated. We record our best estimate of a loss when the loss is considered probable. Where a liability is probable and there is a range of estimated loss with no best estimate in the range, we record the minimum estimated liability related to the claim. As additional information becomes available, we assess the potential liability related to our pending litigation and revise our estimates.

Valuation of Inventory.Our inventory is comprised of raw materials, assemblies and finished products that we intend to sell to our customers.We must periodically make judgments and estimates regarding the future utility and carrying value of our inventory. The carrying value of our inventory is periodically reviewed and impairments, if any, are recognized when the expected future benefit from our inventory is less than its carrying value. In the quarter ended March 31,June 30, 2005, we reviewed the carrying value of our inventory and increaseddecreased the reserve for obsolescence to $293,535 from the level of $349,986 at March 31, 2005. The reserve is primarily for raw materials and finished goods that were used on our older HSS and PMT products for which there is anticipated to be reduced demand.

Results of Operations

Revenues

Revenues for the sixthree months ended March 31,June 30, 2005 were $7,226,306, which was$1,393,797, representing a 219% increase over the $2,268,02834% decrease from $2,107,281 in revenues for the sixthree months ended March 31,June 30, 2004. Revenues for the sixthree months ended March 31,June 30, 2005 and March 31, 2004 included $7,161,206 and $2,111,834$1,378,648 of product sales and $65,100$15,149 of contract and $156,194license revenues. Revenues for the three months ended June 30, 2004 consisted of $2,089,359 of product sales and $17,922 of contract and license revenues. The decrease in revenues was due to reduced sales of LRAD products by our Government Group and reduced sales of HSS products by our Commercial Products Group. The prior year period also included revenues from the sale of a 5MC public address system which we did not market during the current period. Our revenues are highly dependent on the timing of large orders from a small number of customers. We expect continued uneven quarterly revenues in future periods due to the lack of established markets for our proprietary products.

At June 30, 2005, we had $450,000 in deferred revenue consisting of deposits for existing contracts, agreements and licenses.

20


Revenues for the nine months ended June 30, 2005 were $8,620,104, representing a 97% increase from $4,375,309 in revenues for the nine months ended June 30, 2004. Revenues for the nine months ended June 30, 2005 and June 30, 2004 included $8,539,855 and $4,201,193 of product sales, and $80,249 and $174,116 of contract and license revenues, respectively. The increase in product sales was due primarily due to increased sales of LRAD products by our Government Group.

Revenues for the three months ended March 31, 2005 were $2,817,393, which was an 89% increase over the $1,493,250 in revenues for the three months ended March 31, 2004. Revenues for the three months ended March 31, 2005 included $2,814,293 of product sales and $3,100 of contract and license revenues. Revenues for the three months ended March 31, 2004 consisted entirely of product sales. The increase in revenues was primarily due to increased sales of LRAD products by our Government Group.


At March 31, 2005, we had $300,000 in deferred revenue or deposits for existing contracts, agreements and licenses.

We have only a limited record of recurring sales, so we do not consider order backlog to be an important index of future performance at this time. Our backlog is affected by the timing of large orders and order deliveries, especially to government customers. Our order backlog was approximately $128,017$660,000 at March 31,June 30, 2005 and approximately $600,000$46,800 at March 31,June 30, 2004. Backlog orders are subject to modification, cancellation or rescheduling by our customers. Future shipments may also be delayed due to production delays, component shortages and other production and delivery related issues.

Our Commercial Products Group, or Commercial Group, markets and licenses HSS, NeoPlanar and NeoPlanarSoundVector products to companies, which employ audio in consumer, commercial and professional applications. Our Government and Force Protection Systems Group, or Government Group, markets LRAD, NeoPlanar, SoundCluster and HSS products to government and military customers and to the expanding force protection and commercial security markets.

Presented below is a summary of revenues by business segment:

Three Months Ended
March 31,
  Six Months Ended
March 31,
  Three Months Ended
June 30,
 Nine Months Ended
June 30,
 
2005  2004  2005  2004  20052004 2005 2004 

 
 
 
 
 
 
 
 
Revenues:                            
Commercial Products Group$109,523  $455,156  $296,872  $537,095  $172,687 $270,494 $469,560 $807,589 
Government Group  2,707,870    1,038,094    6,929,434    1,730,933   1,221,110  1,836,787  8,150,544  3,567,720 

  
  
  
  



$2,817,393  $1,493,250  $7,226,306  $2,268,028  $1,393,797 $2,107,281 $8,620,104 $4,375,309 

  
  
  
  



Commercial Group revenues for all reported periods consisted primarily of HSS and Neoplanar product sales. The decrease in Commercial Group revenues for the three and six monthsnine month periods ended March 31,June 30, 2004 consisted of multiple small volume sales. Commercial Group revenues for the three and nine month periods ended June 30, 2005 compared to the comparable prior fiscal periods was due toreflect a shift in our marketing focus from multiple small volume sales to pursuit of high volume contracts. These contracts which require much longer sales cycles.cycles, and we had not at June 30, 2005 recognized significant revenues from such contracts.

Government Group revenues for all reported periods consisted primarily of sales of LRAD, NeoPlanar, and NeoPlanar5MC products and engineering services such as installation design and support. These revenues are derived primarily from a limited number of large orders, and the timing of follow-on orders, if any, is difficult to predict. Government Group revenues for the three and six months ended March 31, 2005 were $2,707,870 and $6,929,434 respectively, and consisted primarily of LRAD product sales and engineering services. Government Group sales for the three and sixnine month periods ended March 31, 2004 were $1,038,094 and $1,730,933, respectively, andJune 30, 2005 consisted primarily of LRAD and NeoPlanar product sales and, to a much lesser extent, engineering services.

For the sixthree months ended March 31,June 30, 2005, sales to one customer in the Government Group accounted for 82%62% of total revenues and sales to a second customer in the Government Group, including affiliates of the customer, accounted for 12% of total revenues. For the nine months ended June 30, 2005, sales to one customer in the Government Group accounted for 79% of total revenues and sales to a second customer in the Government Group, including affiliates of the customer, accounted for 10% of total revenues. For the three months ended March 31, 2005,June 30, 2004, sales to one customer in the Government Groupthree customers accounted for 93%62%, 22% and 13% of total revenues.revenues, respectively. For the sixnine months ended March 31,June 30, 2004, sales to two customers in the Government Group accounted for 41%51% and 32%28% of total revenues, respectively, and sales to one customer in the Commercial Group accounted for 11% of total revenues. For the three months ended March 31, 2004, sales to one customer in the Government Group accounted for 62% of total revenues, and sales to one customer in the Commercial Group accounted for 17% of total revenues.respectively. The loss of any one of these significant customers would have a material adverse effect on our results of operations and financial condition.


21


Gross Profit

Presented below is the gross profit or loss by business segment:

Three Months Ended
March 31,
  Six Months Ended
March 31,
  Three Months Ended
June 30,
 Nine Months Ended
June 30,
 
2005  2004  2005  2004  2005 2004 2005 2004 

 
 
 
 
 
 
 
 
Gross Profit (Loss):                            
Commercial Products Group$(408,137)$(73,180)$(612,433)$(76,792)$(91,184)$(167,833)$(703,617)$(244,625)
Government Group  1,771,564    621,206    4,857,070    991,118   493,191  1,268,795  5,350,260  2,259,913 

  
  
  
  



$1,363,427  $548,026  $4,244,637  $914,326  $402,007 $1,100,962 $4,646,643 $2,015,288 

  
  
  
  



The overall gross profit for the sixthree months ended March 31,June 30, 2005 was $4,244,637,$402,007, or 59%29% of revenues, compared to gross profit of $914,326$1,100,962, or 40%52% of revenues, for the comparable period of the prior fiscal year. Gross profit as a percentage of revenues declined over the comparable period of the prior fiscal year as a result of reduced gross profit in our Government Group, offset in part by decreased gross losses in our Commercial Group.

The overall gross profit for the nine months ended June 30, 2005 was $4,646,643, or 54% of revenues, compared to gross profit of $2,015,288, or 46% of revenues, for the comparable period of the prior fiscal year. The significant improvement in gross profit as a percentage of revenues reflected improved gross profit in our Government Group, offset in part by increased gross losses in our Commercial Group.

The overall gross profitGroup and increased expenses for the three months ended March 31, 2005 was $1,363,427 or 48% of revenues, compared to gross profit of $548,026 or 37% of revenues for the comparable period of the prior fiscal year. Gross profit as a percentage of revenues improved over the comparable period of the prior fiscal year as a result of improved gross profit in our Government Group, offset in part by increased gross losses in our Commercial Group.inventory reserves.

We experienced gross losses in our Commercial Group for the three and sixnine months ended March 31,June 30, 2005 of $408,137$91,184 and $612,433$703,617, respectively, as limited sales were not sufficient to absorb fixed manufacturing overhead costs and substantial reserves were taken for obsolete and slow moving inventory, particularly for our older HSS products. For the three and sixnine months ended March 31,June 30, 2004, we had gross losses in our Commercial Group of $73,180$167,833 and $76,292$244,625 respectively, primarily as a result of limited sales compared to fixed overhead and warranty costs. During fiscal year 2003 and fiscal 2004 we changed our HSS Generation 1 emitter design to eliminate the requirement for a vacuum in the emitter, and we improved film quality. During fiscal 2004, we made further raw material improvements in the electronics and the manner in which the film and emitters are produced. In May 2005 we introduced a new, lower-cost model of our HSS product. We believe that future generationsthe latest generation of our products will be more reliable. We expect that warranty costs will decrease in fiscal 2005, and that as the volume of HSS product sales grow, we will achieve positive gross margins in future periods.

Gross profit for our Government Group for the three and sixnine months ended March 31,June 30, 2005, was $1,771,564$493,191 and $4,857,070$5,350,260, respectively, compared to $621,206$1,268,795 and $991,118$2,259,913 for the three and sixnine months ended March 31,June 30, 2004. Cost of revenues for the three and nine months ended June 30, 2005 included $127,214 of costs associated with the partial shipment of an order.  The revenue associated with the order will be recognized upon shipment of complete products which is expected to occur in our fiscal fourth quarter. Gross profit percentage continues to be highly dependent on sales prices, sales volumes, purchasing costs and overhead allocations. Our various sound products have different margins, so product sales mix will materially affect gross profits. In addition, we continue to make model updates and changes including raw material and component changes, which change product costs.costs and may result in expense for raw material and products that are deemed obsolete. We therefore do not believe that historical gross profit margins should be relied upon as an indicator of future gross profit margins.

Selling, General and Administrative Expenses

Selling, general and administrative expenses as a percentagewere 207% of revenues were 57% for the sixthree months ended March 31,June 30, 2005 compared to 95%77% of revenues for the sixthree months ended March 31,June 30, 2004. These costs for the sixthree months ended March 31,June 30, 2005 totaled $4,089,951,$2,879,021, which represents an increase of $1,264,670 from selling, general and administrative expenses of $2,151,786$1,614,351 for the sixthree months ended March 31,June 30, 2004.

22


The overall increase for the sixthree months ended March 31,June 30, 2005 included the following:

$581,02931,989 increase in personnel and related expenses due to increases in headcount and salaries.
 
$213,180296,381 increase in travel and entertainment, marketing expenses and the cost of demonstration units, due to increased sales efforts.
$98,069 increase in commission expenses due to a higher commission rate.
$29,755 increase in insurance expenses.
$259,619 increase in consulting services primarily due to costs associated with compliance with the Sarbanes-Oxley Act of 2002.
$44,275 increase in accounting and auditing expense due to higher fees for services provided.
$46,753 increase in expenses related to board of directors fees, filings and shareholder activities.
$80,000 increase in bad debt expense due to one overdue payment.
$293,826 of impairment charge related to the legal, audit and associated fees originally recorded as prepaid transaction costs associated with the Committed Equity Financing Facility with Kingsbridge. The impairment charge resulted from our decision in June 2005 to terminate such facility.

Selling, general and administrative expenses were 81% of revenues for the nine months ended June 30, 2005 compared to 86% for nine months ended June 30, 2004. These costs for the nine months ended June 30, 2005 totaled $6,968,972, which represents an increase of $3,202,835 from selling general and administrative expenses of $3,766,137 for the nine months ended June 30, 2004. The overall increase for the nine months ended June 30, 2005 included the following:

$591,239 increase in personnel and related expenses due to increases in headcount and salaries.
$311,250 increase in commission expenses resulting from increased sales in our Government Group.
 
$539,399439,313 increase in legal expense related to the litigation which settled in April 2005 and increased legal costs of public company compliance.
 
$210,116534,217 increase in travel and entertainment, and marketing expenses and the cost of demonstration units, as a result of increased sales efforts.

20


$95,537 increase in insurance expenses.
 
$69,724125,291 increase in insurance expenses due to higher business insurance costs and higher Director’s and Officer’s liability insurance.
$101,464 increase in depreciation expenses due to an increase in depreciable capital assets.

Selling, general and administrative expenses as a percentage of sales were 74% for the three months ended March 31, 2005 compared to 72% for the three months ended March 31, 2004. These costs for the three months ended March 31, 2005 totaled $2,094,036, which represents an increase from selling, general and administrative expenses of $1,079,472 for the three months ended March 31, 2004.

The overall increase for the three months ended March 31, 2005 included the following:

$192,213 increase in personnel and related expenses due to increases in headcount and salaries.
 
$474,58676,988 increase in legalaccounting and auditing expense relateddue to the litigation which settled in April 2005, and increased costs of public company compliance.higher fees for services provided.
 
$106,841277,709 increase in travel and entertainment and other marketing related expenses as a resultconsulting services primarily due to costs associated with compliance with the Sarbanes-Oxley Act of increased sales.2002.
 
$87,34380,909 increase in insurance expenses.bad debt expense primarily due to one overdue payment.
 
$44,22560,091 increase in rent expense due to additional space requirements and higher rental rate.
$79,399 non-cash expense for the modification of increased consulting expenses.stock options for a terminated employee.
$293,826 of impairment charge related to the legal, audit and associated fees originally recorded as prepaid transaction costs associated with the Committed Equity Financing Facility with Kingsbridge. The impairment charge resulted from our decision in June 2005 to terminate such facility.

We expect selling, general and administrative expenses to increase in future periods as we increase our marketing efforts for our proprietary sound technologies. We will also incur substantial additional expense over the remainder of fiscal 2005 to improve and document our internal control over financial reporting in anticipation of management’s required assessment of the effectiveness of our internal control over financial reporting and the attestation of such assessment by our independent registered public accounting firm, required by Section 404 of the Sarbanes-Oxley Act of 2002 in connection with our report on Form 10-K for the fiscal year ending September 30, 2005.

23


Research and Development Expenses

Research and development expenses increased by $1,819,789$378,169 from $1,093,219$890,299 to $1,268,468 for the sixthree months ended March 31, 2004 to $2,913,008 for the six months ended March 31,June 30, 2005. Research and development expenses as a percentage of sales were 40%91% for the sixthree months ended March 31,June 30, 2005 compared to 48%42% for the sixthree months ended March 31,June 30, 2004.

The overall increase for the sixthree months ended March 31,June 30, 2005 included the following:

$997,520309,311 increase in personnel and related costs, as we significantly increased our engineering design and development capability.
 
$245,183 non-cash expense associated with the modification of stock options for departing employees.
$538,23945,517 increase for prototypes and other parts relating to our continuing effort to design and develop new and more reliable products.
$41,683 decrease for professional services and consulting expenses.

Research and development expenses increased by $808,145$2,197,958 from $644,248$1,983,518 for the threenine months ended March 31,June 30, 2004 to $1,452,393$4,181,476 for the threenine months ended March 31,June 30, 2005. Research and development expenses as a percentage of sales were 52%49% for the threenine months ended March 31,June 30, 2005 compared to 43%45% for the threenine months ended March 31,June 30, 2004.

The overall increase for the threenine months ended March 31,June 30, 2005 included the following:

$479,3821,306,830 increase in personnel and related costs as we significantly increased our engineering design and development capability.
 
$59,712 decrease245,183 non-cash expense associated with the modification of stock options of terminated employees.
$583,756 increase for consulting expenses.prototypes and other parts relating to our continuing effort to design and develop new and more reliable products.

21


$320,555 increase for prototypes and other parts relating to our continuing effort to design and develop new and more reliable products.

Research and development expenses vary period to period due to the timing of projects, the availability of funds for research and development and the timing and extent of use of outside consulting, design and development firms. We expect our research and development expenses forto decrease in future periods as a result of the remaindercompletion of fiscal 2005 to be higher thanmajor projects and the corresponding periodsreduction in the number of fiscal 2004.employees who are directly involved in product development and technology development.

Loss From Operations

Loss from operations was $2,758,322$3,745,482 for the sixthree months ended March 31,June 30, 2005 compared to $2,330,679$1,403,688 for the sixthree months ended March 31,June 30, 2004. The increase in loss from operations reflected a $1,642,839 increase in total operating expenses, and a decrease of $698,955 in gross profit.

Loss from operations was $6,503,805 for the nine months ended June 30, 2005 compared to $3,734,367 for the nine months ended June 30, 2004. The increase in loss from operations was due to a $3,757,954$5,400,793 increase in total operating expenses, offset in part by an increase of $3,330,311$2,631,355 in gross profit. Losses from operations are expected to continue in the current fiscal year.

Loss from operations was $2,183,002 for the three months ended March 31, 2005 compared to $1,175,694 for the three months ended March 31, 2004. The increase in loss from operations reflected a $1,822,709 increase in total operating expenses, offset in part by an increase of $815,401 in gross profit.24


Other Income (Expense)

We recorded $569,986$152,714 of other income and $381,544$228,830 of other expense for the three and sixnine months ended March 31,June 30, 2005, compared with $10,498$13,277 and $29,056$42,333 of other income for the three and sixnine months ended March 31,June 30, 2004. Other income for the three and nine months ended March 31,June 30, 2005 included $682,210$451,190 and $183,259, respectively, of non-cashunrealized gain on derivative revaluation income related to the decrease in the fair value during the three months ended March 31, 2005 of the warrant issued to Kingsbridge Capital Limited.Limited in December 2004. Other expenseincome for the six monthsthree and nine month periods ended March 31,June 30, 2005 included $267,931was also reduced by a warrant impairment charge of non-cash derivative revaluation expense related to$183,259 in each period, which represented the increase indifference at June 30, 2005 between the fair value of suchthe warrant measured fromdetermined at the issuance date of December 14, 2004issuance and the derivative instrument liability associated with such warrant. The impairment resulted from our decision in June 2005 to March 31,terminate that Kingsbridge financing arrangement, which termination became effective in July 2005. The remaining asset of $659,846 in prepaid transaction costs representing the unimpaired fair value of the warrant at June 30, 2005, and the remaining derivative instrument liability of the same amount, will be offset during the quarter ending September 30, 2005, with no net effect on other income or expense. We also incurred interest expense of $130,631$131,904 and $142,961$274,865 in the three and nine months ended June 30, 2005, primarily due to interest earned on the notes issued in December 2004 and the amortization of the debt discount on those notes. We recognized $18,407$16,687 and $29,348$46,035 of interest income from invested cash balances during the three and sixnine months ended March 31,June 30, 2005. During the three and sixnine months ended March 31,June 30, 2004, we recorded interest expense of $993$454 and $1,809,$2,263, respectively, and $11,491$13,731 and $30,865,$44,596, respectively, of interest income from invested cash balances.

Net Loss

Net loss for sixthe three months ended March 31,June 30, 2005 was $3,139,866$3,592,768 compared to net loss of $2,301,623 for the six months ended March 31, 2004. Net loss$1,390,411 for the three months ended March 31, 2005 was $1,613,016 compared to net loss of $1,165,196 for the three months ended March 31,June 30, 2004. The increase in net loss duringresulted primarily from higher operating expenses and decreases in gross margins from the comparable prior period. The unrealized derivative revaluation credit to expense of $451,190 offset in part by the $183,259 warrant impairment expense recorded for the three months ended June 30, 2005 periodsalso reduced the net loss for the period. Net loss for the nine months ended June 30, 2005 was $6,732,635 compared to net loss of $3,692,034 for the nine months ended June 30, 2004. The increase in net loss for the nine months ended June 30, 2005 as compared to the comparable period in the prior year resulted primarily from higher operating expenses, offset in part by increases in gross margins. The non-cash derivative revaluation expense recorded for the three and six months ended March 31, 2005 contributed to increased net loss for the six month period and reduced the net loss for the three month period.

Net Loss Available to Common Stockholders

Net loss available to common stockholders was increased in each affected period presented in computing net loss per share by the accretion of the value of imputed deemed dividends arising from the beneficial conversion discount and the value of warrants associated with convertible preferred stock outstanding during each period. The imputed deemed dividends were not contractual obligations to pay such imputed dividends. Net loss available to common stockholders iswas also increased by the 6% accretion (similar to a dividend) on outstanding preferred stock. These amounts aggregated $1,518,651 and$-0-and $1,796,426 for the three and sixnine months ended March 31,June 30, 2005, and $406,846$387,019 and $700,551$1,087,570 for the three and sixnine months ended March 31,June 30, 2004. Accordingly, the net loss available to common stockholders was $3,131,667$3,592,768 and $4,936,292$8,529,061 for the three and sixnine months ended March 31,June 30, 2005, and $1,572,042$1,777,430 and $3,002,174$4,779,604 for the three and sixnine months ended March 31,June 30, 2004.

On January 18, 2005, we gave notice to all holders of Series D and Series E Preferred Stock that we had elected to convert the shares of Series D and Series E Preferred Stock to common stock. All 50,000 issued and outstanding shares of Series D Preferred Stock converted into an aggregate of 129,259 shares of common stock on the date of notice, and all 233,250 issued and outstanding shares of Series E Preferred Stock converted into an aggregate of 801,306 shares of common stock on February 1, 2005. As all the Series D and Series E Preferred Stock was called for conversion as described above, $1,504,711 was accreted in the second fiscal quarter, in addition to the accretion of $13,940 at the stated rate of 6%, and increased the net loss available to common stockholders.


Liquidity and Capital Resources

We have experienced significant negative cash flow from operating activities including developing and introducing our proprietary sound technologies. Our net cash used in operating activities was $1,712,084$5,455,018 for the sixnine months ended March 31,June 30, 2005 compared to $3,658,752$4,909,532 for the sixnine months ended March 31,June 30, 2004. For the sixnine months ended March 31,June 30, 2005, the net loss of $3,139,866$6,732,635 included certain expenses not requiring the use of cash totaling $1,012,080.$1,226,685. For the sixnine months ended March 31,June 30, 2005, cash was used in operating activities through an increase of $493,601$1,104,060 in inventory, an increase of $29,773$173,157 in prepaid expenses and an increase of $16,357$86,515 in warranty payments.deductions. Cash was provided in operating activities through a decrease of $432,244$339,439 in accounts receivable, an increase of $523,189$1,075,225 in accounts payable and accrued liabilities.

At March 31,June 30, 2005, we had accounts receivable of $494,503$507,308 as compared to $926,747 at September 30, 2004. The balance at March 31,June 30, 2005 represented approximately 3537 days of revenues. One customer accounted for 56%30% of accounts receivable, and two other customers accounted for 21% each of accounts receivable and a fourth customer accounted for 14% of accounts receivable at March 31, 2005,June 30, 2005. No other customer accounted for more than 10% of accounts receivable at March 31,June 30, 2005. Terms with individual customers vary greatly. We typically require pre-payment or a maximum of thirty-day terms for our proprietary sound technology products. Our receivables can also vary substantially due to overall sales volumes and due to quarterly and seasonal variations in sales and timing of shipments to and receipts from large customers and the timing of contract payments.

25


For the sixnine months ended March 31,June 30, 2005 and March 31,June 30, 2004 we used cash of $355,995$448,535 and $104,765,$299,623, respectively, for the purchase of equipment and software and made investments of $144,420$187,579 and $204,819,$254,096, respectively, in patents and new patent applications. We anticipate a continued investment in patents for the balance of fiscal 2005.

Cash from financing activities provided $4,195,940$4,281,755 and $697,540$1,099,026 for the sixnine months ended March 31,June 30, 2005 and March 31,June 30, 2004. During the sixnine months ended March 31,June 30, 2005, we received $2,000,000 from the sale of unsecured promissory notes, $1,661,277 from the exercise of common stock warrants and $643,802$649,577 from the exercise of stock options. During the sixnine months ended March 31,June 30, 2004, we received $50,000 from the exercise of common stock warrants and $653,202$1,056,367 from the exercise of common stock options.

At March 31,June 30, 2005, we had working capital of $4,690,763$1,365,194 compared to working capital of $3,472,984 at September 30, 2004.

In December 2004, we sold for cash in a private offering an aggregate of $2,000,000 of unsecured subordinated promissory notes due December 31, 2006. In connection with the financing, we also issued five-year warrants to purchase an aggregate of 150,000 shares, 75,000 of which have an exercise price of $9.28 per share, and 75,000 of which have an exercise price of $8.60 per share. A trust affiliated with Elwood G. Norris, our Chairman and the beneficial owner of 19.5% of our common stock before the financing, purchased a note in the principal amount of $500,000 and received a warrant exercisable for 37,500 shares with an exercise price of $9.28 per share. In July 2005, we redeemed the notes and paid all interest due using proceeds from the financing described below.

In December 2004,July 2005, we sold 2,868,851 shares of common stock at a purchase price of $4.88 per share. We also issued warrants in two series to the investors to purchase 1,581,919 shares of common stock. The “A” Warrants are exercisable for an aggregate of 717,213 shares of common stock at an exercise price of $6.36 per share until July 18, 2009. The “B” Warrants are exercisable for an aggregate of 864,706 shares of common stock at an exercise price of $7.23 per share and are exercisable from the date the registration statement referred to below becomes effective until the date six months after that effective date.

The gross proceeds from this financing were $14 million. We incurred financing and closing costs of approximately $740,000. We entered into a Committed Equity Financing Facility (CEFF)registration rights agreement with Kingsbridge Capital Limited, pursuantthe investors, and agreed to which Kingsbridge committed,prepare and file, within 30 days a registration statement covering the resale of the shares of common stock sold and the common stock issuable upon the exercise of the warrants. Failure to have an effective registration statement within 90 days obligates us to pay liquidated damages to the purchasers in the amount of 0.5% of the gross proceeds per month until 180 days after the closing, and 1% of the gross proceeds per month thereafter. We used approximately $2.0 million of the gross proceeds to discharge the principal balance of and accrued interest on the unsecured subordinated promissory notes described above.

We have also agreed to submit the financing to a vote of our stockholders for approval prior to June 2006. We further agreed that, subject to certain significant limiting conditions, to purchase up to $25 millionexceptions, if during the next year we sell shares of our common stock, to support future growth. As part of the arrangement, we issued a warrant to Kingsbridgeor options or warrants to purchase 275,000shares of our common stock, in a private placement or in a public offering using a Form S-3, the purchasers will have certain rights of first refusal to participate in the financing. We have also agreed to indemnify the purchasers for certain losses.

The “A” Warrants and “B” Warrants contain provisions that would adjust the exercise price, and in inverse proportion adjust the number of shares subject to the warrant, in the event we pay or effect stock dividends or splits, or in the event we sell shares of our common stock at a purchase price, of $8.60 per share. The warrant is exercisable beginning six months after the date of grant and for a period of five years thereafter. Subject to certain conditions and limitations, from time to time under the CEFF, we may require Kingsbridgeor options or warrants to purchase newly-issued shares of our common stock at ahaving an exercise price, that is between 88% and 92%less than the exercise price of the volume weighted average price duringapplicable warrant. The “A” Warrants also feature a 15 day purchase period, and thereby raise capital as required, atnet exercise provision, which enables the time, price and inholder to choose to exercise the amounts deemed suitablewarrant without paying cash by surrendering shares subject to us. For each electionthe warrant with a market value equal to sell shares to Kingsbridge, we select the lowest threshold price at which our stock may be sold, but the threshold price cannot be lower than $3.00 per share. Our agreement with Kingsbridge permits Kingsbridge to terminate the CEFFexercise price. This right is available only if Kingsbridge determines that a material and adverse event has occurred affecting the business, operations, properties or financial condition of our company, or if any situation occurs that would interfere with our ability to perform any of our obligations under the agreement.


The CEFF requires us to have a resale registration statement filed within 45 days of entering intocovering the CEFF, andshares subject to use commercially reasonable efforts to have such registration statement declared effective by the Securities and Exchange Commission (SEC) within 45 days or 120 days of filing, depending on whether the SEC elects to review the registration statement. The required registration statement was filed in January 2005. The resale statement has“A” Warrants is not yet beenavailable after it is initially declared effective. We cannot electhave the right to sellredeem the “B” Warrants if the closing price of the shares to Kingsbridge until the registration statementof our common stock is effective.

In certain instances, we may be required to pay liquidated damages$10.00 or other amounts resulting from the unavailability of a registration statement. For further details, see “Business Risks” below.

Based on such factors as market conditions, financing needsgreater for 15 consecutive trading days and the time required for the SEC to declare the resale registration statement effective,holder does not exercise within 20 days after we currently expect that we may begin to utilize the CEFF during fiscal 2005 in order to fund working capital requirements. However, the timing and extentgive notice of our ability to utilize the CEFF is uncertain. We are obligated to use 40% of the proceeds we may receive from the CEFF to prepay any outstanding interest and principal on the notes sold in December 2004. Under the rules of the Nasdaq Stock Market, the maximum number of shares we may sell to Kingsbridge without approval of our stockholders is 3,684,782, which includes any shares we may issue in lieu of paying liquidated damages, but excludes the warrant shares. This limitation may further reduce the amount of proceeds we are able to obtain from the CEFF. We agreed to pay to a consultant a finder fee equal to 4% of the first $5 million raised under the CEFF, 3% for the second $5 million raised under the CEFF, 2% for the third $5 million raised under the CEFF, and 1.5% for any additional amounts raised under the CEFF. See “Business Risks” below for a discussion of other risks associated with the CEFF.redemption.

26


Other than cash and cash equivalents, and the CEFF, we have no other unused sources of liquidity at this time. We expect to incur additional operating losses as a result of expenditures for research and development and marketing costs for our sound products and technologies. The timing and amounts of these expenditures and the extent of our operating losses will depend on many factors, some of which are beyond our control.

PrincipalIn July 2005 we entered into a termination, settlement and release agreement with Kingsbridge Capital Limited. Under the terms of this agreement, we and Kingsbridge agreed that the common stock purchase agreement we entered into with Kingsbridge in December 2004, and the related registration rights agreement and warrant we issued to Kingsbridge of the same date, would be terminated, and Kingsbridge would return the warrant, which has not been exercised, to us for cancellation. We incurred no early termination penalties in connection with this termination. The termination agreement contains a mutual release of claims.

The termination agreement resulted from our determination that the common stock purchase agreement was no longer consistent with our financing plans, due to various factors, that could affect the availability of our internally generated funds include:including anticipated capital requirements and timing, market conditions, and SEC requirements for transaction structure.

government spending levels;

introduction of competing technologies;

failure of sales from our Government Group and Commercial Group to meet planned projections;

product mix and effect on margins; and

product acceptance in new markets.

Principal factors that could affect the availability to obtain cash from external sources include:

inability to have the registration statement required by the CEFF declared effective by the SEC;

decrease in the market price of our common stock, which may render the CEFF unavailable (if the purchase price under the CEFF would be less than $3.00 per share), or which may make the CEFF a less attractive funding source.;

our failure to satisfy other required conditions for use of the CEFF;

the trading volume of public trading of our common stock; and

overall market conditions.

Based on our current cash position, and assuming currently planned expenditures and level of operations, we believe we will have sufficient cash for operations for at least the next twelve months. We believe increased sales of LRAD, MRAD, HSS and, to a lesser extent, NeoPlanar products, will continue to contribute cash in fiscal 2005. We believeIn the event that any investment capital we may require will be available to us, butneed additional funds, there can be no guarantee that we will be able to raise funds on terms acceptable to us, or at all. We have flexibility to adjust the level of research and development and selling and administrative expenses based on the availability of resources. However, reductions in expenditures could delay development and adversely affect our ability to generate future revenues.


Contractual Commitments and Commercial Commitments

The following table summarizes our contractual obligations at March 31,June 30, 2005, and the effect such obligations are expected to have on our liquidity and cash flow in future periods:

    Less than 1    After 5  
Contractual Obilgations  Total  Year  1-3 Years  4-5 Years  Years  

 




Capital leases $21,344  $12,806  $8,538      
Operating leases   355,827    245,033    110,794      
Long Term Debt   2,000,000         2,000,000      





Total contractual cash obligations $2,377,171  $257,839  $2,119,332      





 
Payments Due by Period
Contractual Obligations Total Less than 1
Year
 1-3 Years 4-5 Years After 5
Years
Capital leases$18,142 $12,806 $5,336  
Operating leases 291,282  239,171  52,110  
Long term debt 2,000,000    2,000,000  





Total contractual cash obligations$2,309,424 $251,977 $2,057,446  





The Company had no material purchase obligations at March 31,June 30, 2005.

New Accounting Pronouncements

A number of new pronouncements have been issued for future implementation as discussed in the footnotes to our interim financial statements (see Note 5).

Business Risks

An investment in our company involves a high degree of risk. In addition to the other information included in this report, you should carefully consider the following risk factors in evaluating an investment in our company. You should consider these matters in conjunction with the other information included or incorporated by reference in this report. Our results of operations or financial condition could be seriously harmed, and the trading price of our common stock may decline due to any of these or other risks.

27


We have a history of net losses. We expect to continue to incur net losses and we may not achieve or maintain profitability.

We have incurred significant operating losses and anticipate continued losses in the remainder of fiscal 2005. At March 31,June 30, 2005, we had an accumulated deficit of $45,467,359.$49,060,128. We need to generate additional revenue to be profitable in future periods. Failure to achieve profitability, or maintain profitability if achieved, may cause our stock price to decline.

We may need additional capital for growth. 

Our current plans indicate that depending on sales, we may need additional capital to support our growth. We may generate a portion of these funds from operations.

The actual amount of funds that we will need will be determined by many factors, some of which are beyond our control, and we may need funds sooner than currently anticipated. Principal factors that could affect the availability of our internally generated funds include:

 

government spending levels;

  
 

introduction of new competing technologies;

  
 

failure of sales from our Government Group and Commercial Group to meet planned projections;

  

25


 

product mix and effect on margins; and

  
 

acceptance of our products in new markets.

When we require additional funds, general market conditions or the then-current market price of our common stock may not support capital raising transactions. If we require additional funds and we are unable to obtain them on a timely basis or on terms favorable to us, we may be required to scale back our research and development efforts, sell or license some or all of our technology or assets or curtail or cease operations. If we raise additional funds by selling additional shares of our capital stock or securities convertible into common stock, the ownership interest of our stockholders will be diluted.

If our stock price falls below $3.41 per share we will be unable to draw down on the CEFF unless the stock price increases. The potential unavailability of this facility would negatively affect our financing activities.

We have entered into a Committed Equity Financing Facility, or CEFF, with Kingsbridge Capital Limited. Under the terms of our agreement with Kingsbridge, we may, at our sole discretion, sell to Kingsbridge, and Kingsbridge would be obligated to purchase, shares of our common stock for up to $25 million in proceeds to us. The price at which we may sell shares of common stock under the agreement is based on a discount to the volume weighted average market price of the common stock for fifteen trading days following each of our elections to sell shares. For each election to sell shares, we select the lowest threshold price at which our stock may be sold, but the threshold price cannot be lower than $3.00 per share. In the event the market price of our common stock falls below $3.41 per share, which after giving effect to the discount would result in a price per share lower that the $3.00 minimum threshold price, the CEFF will not be an available source of financing. Our stock has traded below $3.41 per share during many in the past, including most recently during May 2003. In addition, we are obligated to use 40% of the proceeds we may raise from the CEFF to prepay any outstanding interest and principal on promissory notes we sold in December 2004 with an aggregate principal amount of $2,000,000. Our agreement with Kingsbridge permits Kingsbridge to terminate the CEFF if Kingsbridge determines that a material and adverse event has occurred affecting the business, operations, properties or financial condition of our company, or if any situation occurs that would interfere with our ability to perform any of our obligations under the agreement.

If we are unable to draw down on the CEFF, and are otherwise unable to obtain capital from other sources on a timely basis or on terms favorable to us, we may be required to scale back our marketing and research and development efforts, sell or license some or all of our technology or assets or curtail or cease operations.

If Kingsbridge determines that a material and adverse event has occurred that affects our company, we will be unable to draw down on the CEFF. The potential unavailability of this facility would negatively affect our financing activities.

Our agreement with Kingsbridge permits Kingsbridge to terminate the CEFF if Kingsbridge determines that a material and adverse event has occurred affecting the business, operations, properties or financial condition of our company, or if any situation occurs that would interfere with our ability to perform any of our obligations under the agreement. If we are unable to draw down on the CEFF, and are otherwise unable to obtain capital from other sources on a timely basis or on terms favorable to us, we may be required to scale back our marketing and research and development efforts, sell or license some or all of our technology or assets or curtail or cease operations.


Each advance under the CEFF is limited. We may not draw down on the CEFF when Kingsbridge beneficially owns in excess of 9.9% of our outstanding shares. The potential unavailability of this facility would negatively affect our financing activities.

Each draw down election we make is limited to a maximum of 3% of our market capitalization at the time of the election, and cannot in any case exceed $10 million. We must also wait at least five trading days after the end of a fifteen trading day draw down period before we can commence the next draw down. In addition, the CEFF limits the beneficial ownership of Kingsbridge to 9.9% of our outstanding common stock, which percentage includes any shares of common stock purchased pursuant to the CEFF, that we may issue as liquidated damages, and issued upon exercise of the warrant. Depending on the market price of our common stock and Kingsbridge’s other holdings of our common stock, this restriction may limit the maximum amount we can draw down under the CEFF. If Kingsbridge’s beneficial ownership were to exceed 9.9% of our outstanding common stock, together with the total amount of our common stock that would be outstanding upon completion of a draw down, we would not be able to draw down on the Committee Equity Facility until such time as Kingsbridge sells enough shares of our common stock or our number of shares of common stock outstanding increases, which may not occur. Therefore, we may not be able to draw down on the full $25 million commitment.

Our sales of stock to Kingsbridge will be discounted to market price, so our stockholders will experience immediate dilution in the value of their shares if we sell shares to Kingsbridge under the CEFF.

The issuance of shares under the CEFF will have a dilutive impact on other stockholders, and the issuance or even potential issuance of such shares could have a negative effect on the market price of our common stock. In addition, if we draw down the CEFF, we will issue shares to Kingsbridge at a discount ranging from 8% to 12% of the daily volume weighted average prices of our common stock during the fifteen day trading period after initiation of each draw down. Issuing shares at such a discount will further dilute the interests of other stockholders. The 9.9% limitation on Kingsbridge’s beneficial ownership will not prevent Kingsbridge from selling some of its holdings and then receiving additional shares, such that the total number of shares that we may sell to Kingsbridge under the CEFF and it resells is greater than 9.9% of our outstanding stock.

There are a large number of shares underlying the CEFF that we are in the process of registering in a registration statement, and the sale of these shares may depress the price of our common stock.

To the extent that Kingsbridge sells shares of our common stock issued under the CEFF under an effective registration statement, our stock price may decrease due to the additional selling pressure in the market. The perceived risk of dilution from sales of stock to or by Kingsbridge may cause holders of our common stock to sell their shares, which could contribute to a decline in our stock price.

The sale of shares underlying the CEFF could encourage short sales by third parties, which could contribute to the future decline of our stock price.

A significant downward pressure on the price of our common stock caused by the sale of material amounts of common stock under the CEFF could encourage short sales by third parties. In a short sale, a prospective seller borrows stock from a stockholder or broker and sells the borrowed stock. The prospective seller hopes that the stock price will decline, at which time the seller can purchase shares at a lower price to repay the lender. The seller profits when the stock price declines because it is purchasing shares at a price lower than the sale price of the borrowed stock. Such sales could place downward pressure on the price of our common stock by increasing the number of shares being sold, which could contribute to the future decline of our stock price.

We cannot predict the actual number of shares that we will issue under the CEFF, in any particular draw down, or in total. The number of shares we will issue will fluctuate based on the market price of our stock over the fifteen trading days after we give a draw down notice for each draw down period.

The actual number of shares that we will issue under the CEFF in any particular draw down, and in total, is uncertain. Subject to the limitations in our agreement with Kingsbridge, we have the discretion to draw down funds at any time throughout the term of the CEFF, and we have not determined the amount of proceeds, if any, we will seek to raise through the CEFF. Also, the number of shares we must issue after giving a draw down notice will fluctuate based on the market price of our stock over the fifteen trading days after we give a draw down notice, and Kingsbridge will receive more shares if our stock price declines. Assuming the volume weighted average price of our common stock is $8.36 per share, which was the closing sale price reported on the NASDAQ SmallCap Market on April 15, 2005, and we elected to draw down a total of $10 million under the CEFF, we would issue 1,329,080 shares of common stock to Kingsbridge, representing 5.9% of our common stock outstanding as of April 15, 2005, after giving effect to the sale of such shares. Using the same assumptions and conditions but with elections by us to draw down the full $25 million under the CEFF, we would issue 3,322,700 shares of common stock to Kingsbridge, representing 13.5% of our common stock outstanding on April 15, 2005, after giving effect to the sale of such shares. During the one year period ended April 15, 2005, our stock price as reported on the NASDAQ SmallCap Market ranged from a high of $11.55 to a low of $4.38.


The above estimates of the number of shares to be sold assume that our stock price would remain constant during each fifteen trading day draw down period, and across all draw down periods. This assumption is not realistic, particularly since during each fifteen trading day draw down period, Kingsbridge is permitted to sell the shares to be issued with respect to each trading day once the discount purchase price for such day (and therefore the number of shares to be purchased for such day) is determined. These permitted sales during a draw down period may cause the volume weighted average price of our common stock to decline on immediately subsequent days, resulting in the sale of additional shares to Kingsbridge on immediately subsequent days for the same monetary proceeds to us. The further sale of shares priced on those immediately subsequent days could then cause further price declines on later days, resulting in the sale of increasing numbers of shares for the same monetary proceeds as the draw down period progresses.

Furthermore, Kingsbridge’s 9.9% beneficial ownership limitation is determined on, and based on the amount of our common stock outstanding on, each settlement date. As the number of shares outstanding on each settlement date increases, Kingsbridge may be required to purchase more shares of our common stock during a draw down period than would have been apparent on the date that we sent the draw down notice to Kingsbridge.

We may issue additional common stock in the future, including shares under our CEFF, and this stock may reduce the value of your common stock.

As a result of the CEFF or otherequity financings we may issue additional shares of common stock without further action by our stockholders. Moreover, the economic and voting interests of each stockholder will be diluted as a result of such issuances. Although the number of shares of common stock that stockholders presently own will not decrease, such shares will represent a smaller percentage of our total shares that will be outstanding after such events. If we satisfy the conditions that allow us to draw down the entire $25 million available under the CEFF, and we choose to do so, then generally, as the market price of our common stock decreases, the number of shares we will have to issue upon each draw down on the CEFF increases, to a maximum of 3,684,782 shares we may issue without stockholder approval. Drawing down on the CEFF when the price of our common stock is decreasing will have an additional dilutive effect to your ownership percentage and may result in additional downward pressure on the price of our common stock.

Sales of common stock issuable on the exercise of outstanding options and warrants, including the warrant held by Kingsbridge, may depress the price of our common stock.

As of April 15, 2005, there were options granted to our employees, directors and consultants to purchase 2,129,311 shares of our common stock. As of April 15, 2005, there were warrants granted to investors to purchase 2,308,234 shares of our common stock, including the warrant issued to Kingsbridge exercisable for 275,000 shares. The exercise prices for the options and warrants range from $2.00 to $11.00 per share. In the future we may issue additional convertible securities, options and warrants. The issuance of shares of common stock issuable upon the exercise of convertible securities, options or warrants could cause substantial dilution to holders of common stock, and the sale of those shares in the market could cause the market price of our common stock to decline. The potential dilution from these shares could negatively affect the terms on which we could obtain equity financing.

Our CEFF imposesimpose certain liquidated damages which may impair our liquidity and ability to raise capital.  

The termsIn connection with our July 2005 equity financing, we entered into a registration rights agreement with some of the CEFF require usinvestors, pursuant to which we agreed to prepare and file a registration statement covering the resale of the shares of common stock sold in the financing as well as the shares of common stock issuable upon the exercise of the warrants sold in the financing. If, among other reasons, those selling stockholders are unable to re-sell their shares purchased in the financing or acquired upon exercise of their related warrants, we may be obligated to pay liquidated damages to those selling stockholders in the event that a registration statement is not available for the resaleamount of securities purchased by Kingsbridge under the CEFF. These liquidated damages provisions generally require us to pay an amount based on the decline in value, if any, of shares held by Kingsbridge during the time a registration statement is unavailable. The liquidated damages could severely affect our liquidity, or to the extent we are permitted to and decide to pay such damages through the issuance of common stock, cause significant dilution to our common stockholders.


We may not issue convertible securities with a floating or adjustable discount to the price of our common stock during the two year term0.5% of the Common Equity Financing Facility withoutgross proceeds we received in that financing per month until January 14, 2006, and 1% of those gross proceeds per month thereafter. Similar provisions regarding the prior written consent of Kingsbridge, which consent we may not be able to obtain. These restrictions may affect our ability to raise capital.

During the two-year term of the proposed CEFF, without the prior written consent of Kingsbridge, we are prohibited from issuing securities that are, or may become, convertible or exchangeable into shares of common stock where the purchase, conversion or exchange price for such common stock is determined using a floating or otherwise adjustable discount to the market price of the common stock (including pursuant to an equity line or other financing that is substantially similar to an equity line with an investor other than Kingsbridge). In the past, we met our capital needs through the sale of preferred stock and convertible notes which had floating price features. We may have difficulty raising capital if Kingsbridge does not consent to our use of such securities in the future. If we are unable to raise capital from Kingsbridge or from sources that do not demand a floating price feature, we may have to severely curtail our operations, which could cause a significant decrease in the price of our common stock.

Our ability to draw down on the CEFF may be limited under the rules of the NASDAQ Stock Market.

Under the rules of the NASDAQ Stock Market, the approval of our stockholders is required for the sale of shares to Kingsbridge totaling more than 20% of our issued and outstanding shares at the time we entered into the agreement with Kingsbridge. If our average sale price to Kingsbridge is below $6.78 per share (equivalent to a volume weighted average price of $7.54 per share, assuming a 10% discount for all sales) and we elect to draw the full $25 million commitment, it would require that we issue more than 20% of our issued and outstanding shares at the time we entered into the agreement with Kingsbridge and we would need to seek stockholder approval to do so. The $6.78 average sale price mentioned above assumes that we have not issued Kingsbridge any shares in lieu of paying liquidated damages that may be owed to Kingsbridge in the event that the availability of its registration statement is suspended. If we issue shares to Kingsbridge in lieu of payment of liquidated damages the average sale price (and the volume weighted average price) would needapply to be highera financing we entered into in order to elect to draw the full $25 million commitment without stockholder approval. If we are unable to obtain such stockholder approval, our ability to raise capital under the CEFF will be impaired. If we are unable to obtain capital from other sources on a timely basis or on terms favorable to us, we may be required to scale back our marketingJuly 2003. The registration statement for that financing has been filed and researchis currently effective.

Two customers and development efforts, sell or license some or all of our technology or assets or curtail or cease operations.

One customertheir affiliates accounted for approximately 93%74% of our revenues for the three months ended March 31,June 30, 2005, the same two customers and their affiliates accounted for92% 89% of our revenues for the sixnine months ended March 31,June 30, 2005, and we continue to be dependent on a few large customers.

ADS, Inc., a prime vendor to the U. S. military, accounted for 93%62% of net revenues for the three months ended March 31, 2005.June 30, 2005 and a second customer and its affiliates accounted for 12% of revenues for the period. For the sixnine months ended March 31,June 30, 2005, ADS accounted for 82%79% of our revenues and a second customer and its affiliates accounted for 10% of our revenues. These customers have the right to cease doing business with us at any time. If this were to occur and we could not replace them, our net revenues couldwould decline substantially. Any such decline could result in us incurring net losses, increasing our accumulated deficit and causing us to need to raise additional capital to fund our operations.

28


We must expand our customer base in order to grow our business.

To grow our business, we must fulfill orders from our existing customers, obtain additional orders from our existing customers, develop relationships with new customers and obtain and fulfill orders from new customers. We cannot guarantee that we will be able to increase our customer base. Further, even if we do obtain new customers, we cannot guarantee that those customers will purchase from us enough quantities of our product or at product prices that will enable us to recover our costs in acquiring those customers and fulfilling those orders. Whether we will be able to sell more of our products will depend on a number of factors, including:

our ability to manufacture reliable products that have the features that are required by our customers; 

29


 

our ability to manufacture reliable products that have the features that are required by our customers; 

our ability to expand relationships with existing customers and to develop relationships with new customers that will lead to additional orders for our products; 

  
 

our ability to develop and expand new markets for directed sound products; and 

  
 

our ability to develop international product distribution directly or through strategic partners.

The growth of our Government Group revenues is materially dependent on acceptance of our LRAD and MRAD products by government, military and developing force protection and emergency response agencies, and if these agencies do not purchase our products, our revenues will be adversely affected.

Although our LRAD and MRAD products are designed for use by both government and commercial customers, our LRADthe products have, to date, been predominantly sold for government use. Within the Government Group, our largest customer is a reseller of our products to end users in various branches of the military such as the U.S. Navy, U.S. Marine Corps, U.S. Army and the Department of Homeland Security. We have only recently achieved significant sales of LRAD products and are beginning to offer MRAD products for sale in our fiscal fourth quarter, and neither of the product has not yetproducts have been widely accepted in the government market. Furthermore, the force protection and emergency response market is itself an emerging market which is changing rapidly. If our LRAD product isand MRAD products are not widely accepted by the government, military and the developing force protection and emergency response markets, we may not be able to identify other markets, and we may fail to achieve our sales projections.

Perceptions that long range hailing devices are unsafe or may be used in an abusive manner may hurt sales of our LRAD and MRAD products which could cause our revenues to decline.

Potential customers for our LRAD and MRAD products, including government, military and force protection and emergency response agencies may be influenced by claims or perceptions that long range hailing devices are unsafe or may be used in an abusive manner. These claims or perceptions could cause our product sales to decline. In addition, if these agencies have these perceptions, it will be difficult for us to grow our customer base beyond these markets. These factors could reduce future revenues, adversely affecting our financial condition and results of operations.

We are an early stage company introducing new products and technologies. If commercially successful products are not produced in a timely manner, we may be unprofitable or forced to cease operations.

Our HSS, NeoPlanar, LRAD and LRADMRAD technologies have only recently been introduced to market and are still being improved. Commercially viable sound technology systems may not be successfully and timely produced by us due to the inherent risks of technology development, new product introduction, limitations on financing, manufacturing problems, competition, obsolescence, loss of key technical personnel and other factors. Revenues from our sound products have been limited to date and we cannot guarantee significant revenues in the future. The development and introduction of our products took longer than anticipated by management and the introduction of new products could also be subject to delays. Customers may not wait for newer versions of existing products or new products and may elect to purchase products from competitors. We experienced quality control problems with some of our initial commercial HSS units, and we may not be able to resolve future similar problems in a timely and cost effective manner. Products employing our sound technology may not achieve market acceptance. Our various sound projects are high risk in nature, and unanticipated technical obstacles can arise at any time and result in lengthy and costly delays or result in a determination that further exploitation is unfeasible. If we do not successfully exploit our technology, our financial condition, and results of operations and business prospects would be adversely affected.

29


Our products have never been produced in quantity, and we may incur significant and unpredictable warranty costs as these products are mass produced.

None of our products has been produced in sufficient quantities to be considered mass produced. Our technologies are substantially different from proven, mass produced sound transducer designs. We may incur substantial and unpredictable warranty costs from post-production product or component failures. We generally warrant our products to be free from defects in materials and workmanship for a period up to one year from the date of purchase, depending on the product.


At March 31,June 30, 2005, we had a warranty reserve of $238,837.$228,487. We recorded substantial warranty reserves for early versions of our HSS products and have little history to predict future warranty costs. Future warranty costs could further adversely affect our financial position, results of operations and business prospects.

We could incur charges for excess and obsolete inventory.

Due to rapidly changing technology and uneven customer demand, product cycles tend to be short and the value of our inventory may be adversely affected by changes in technology that affect our ability to sell the products in our inventory. Therefore, periodically, it may be necessary to write off inventory as excess or obsolete.

While we will make every attempt to successfully manage product transition, including inventory control of older generation products when introducing new products, we have previously experienced and may, in the future, experience reductions in sales of older generation products as customers delay or defer purchases in anticipation of new product introductions. We currently have established reserves for slow moving or obsolete inventory. The reserves we have established for potential losses due to obsolete inventory may, however, prove to be inadequate and may give rise to additional charges for obsolete or excess inventory.

We do not have the ability to predict future operating results. Our quarterly and annual revenues will likely be subject to fluctuations caused by many factors, any of which could result in our failure to achieve our revenue expectations.

We expect our sound proprietary reproduction technologies will be the source of substantially all of our future revenues. Revenues from our sound proprietary reproduction technologies are expected to vary significantly due to a number of factors. Many of these factors are beyond our control. Any one or more of the factors listed below or other factors could cause us to fail to achieve our revenue expectations. These factors include:

 

our ability to develop and supply sound reproduction components to customers, distributors or OEMs or to license our technologies;

  
 

market acceptance of and changes in demand for our products or products of our customers;

  
 

gains or losses of significant customers, distributors or strategic relationships;

  
 

unpredictable volume and timing of customer orders;

  
 

the availability, pricing and timeliness of delivery of components for our products and OEM products;

  
 

fluctuations in the availability of manufacturing capacity or manufacturing yields and related manufacturing costs;

  
 

the timing of new technological advances, product announcements or introductions by us, by OEMs or licensees and by our competitors;

  
 

product obsolescence and the management of product transitions and inventory;

  
 

unpredictable warranty costs associated with new product models;

  
 

production delays by customers, distributors, OEMs or by us or our suppliers;

  
 

seasonal fluctuations in sales;

  
 

the conditions of other industries, such as military and commercial industries, into which our technologies may be licensed;

31


 

general consumer electronics industry conditions, including changes in demand and associated effects on inventory and inventory practices;

  
 

general economic conditions that could affect the timing of customer orders and capital spending and result in order cancellations or rescheduling; and

  
 

general political conditions in this country and in various other parts of the world that could affect spending for the products that we offer.

30



Some or all of these factors could adversely affect demand for our products or technologies, and therefore adversely affect our future operating results.

Most of our operating expenses are relatively fixed in the short term. We may be unable to rapidly adjust spending to compensate for any unexpected sales or license revenue shortfalls, which could harm our quarterly operating results. We do not have the ability to predict future operating results with any certainty.

Our expenses may vary from period to period, which could affect quarterly results and our stock price.

If we incur additional expenses in a quarter in which we do not experience increased revenue, our results of operations would be adversely affected and we may incur larger losses than anticipated for that quarter. Factors that could cause our expenses to fluctuate from period to period include: 

 

the value of our stock price, which impacts the income or expense we record each quarter for the warrant issued to Kingsbridge; 

the timing and extent of our research and development efforts;

  
 

investments and costs of maintaining or protecting our intellectual property;

  
 

the extent of marketing and sales efforts to promote our products and technologies; and

  
 

the timing of personnel and consultant hiring.

Many potential competitors who have greater resources and experience than we do may develop products and technologies that make ours obsolete.

Technological competition from other and longer established electronic and loudspeaker manufacturers is significant and expected to increase. Most of the companies with which we expect to compete have substantially greater capital resources, research and development staffs, marketing and distribution programs and facilities, and many of them have substantially greater experience in the production and marketing of products. In addition, one or more of our competitors may have developed or may succeed in developing technologies and products that are more effective than any of ours, rendering our technology and products obsolete or noncompetitive.

Sound reproduction markets are subject to rapid technological change, so our success will depend on our ability to develop and introduce new technologies.

Technology and standards in the sound reproduction markets evolve rapidly, making timely and cost-effective product innovation essential to success in the marketplace. The introduction of products with improved technologies or features may render our technologies obsolete and unmarketable. If we cannot develop products in a timely manner in response to industry changes, or if our technologies do not perform well, our business and financial condition will be adversely affected. The life cycles of our technologies are difficult to estimate, particularly those such as HSS, LRAD and LRADMRAD for which there are no well-establishedwell established markets. As a result, our technologies, even if successful, may become obsolete before we recoup our investment.


Our competitive position will be seriously damaged if we cannot obtain patent protection for important differentiating aspects of our products or otherwise protect intellectual property rights in our technology.

We rely on a combination of contracts and trademark, patent and trade secret laws to establish and protect our proprietary rights in our technology. However, we may not be able to prevent misappropriation of our intellectual property, our competitors may be able to independently develop and the agreements we enter into may not be enforceable.

31


Our success, in part, depends on our ability to obtain and enforce intellectual property protection for our technology, particularly our patents. There is no guarantee any patent will issue on any patent application that we have filed or may file. Claims allowed from existing or pending patents may not be of sufficient scope or strength to protect the economic value of our technologies. Further, any patent that we may obtain will expire, and it is possible that it may be challenged, invalidated or circumvented. If we do not secure and maintain patent protection for our technology and products, our competitive position will be significantly harmed because it will be much easier for competitors to sell products similar to ours. Alternatively, a competitor may independently develop or patent technologies that are substantially equivalent to or superior to our technology. For example, patent protection on our LRAD productand MRAD products is limited, and we may not be able to prevent others from introducing products with similar functionality. If this happens, any patent that we may obtain may not provide protection and our competitive position could be significantly harmed.

As we expand our product line or develop new uses for our products, these products or uses may be outside the protection provided by our current patent applications and other intellectual property rights. In addition, if we develop new products or enhancements to existing products we cannot assure you that we will be able to obtain patents to protect them. Even if we do receive patents for our existing or new products, these patents may not provide meaningful protection. In some countries outside of the United States where our products can be sold or licensed, patent protection is not available. Moreover, some countries that do allow registration of patents do not provide meaningful redress for violations of patents. As a result, protecting intellectual property in these countries is difficult and our competitors may successfully sell products in those countries that have functions and features that infringe on our intellectual property.

We may initiate claims or litigation against third parties in the future for infringement of our proprietary rights or to determine the scope and validity of our proprietary rights or the proprietary rights of our competitors. These claims could result in costly litigation and divert the efforts of our technical and management personnel. As a result, our operating results could suffer and our financial condition could be harmed.

Our competitive position will be seriously damaged if our products are found to infringe on the intellectual property rights of others.

Other companies and our competitors may currently own or obtain patents or other proprietary rights that might prevent, limit or interfere with our ability to make, use or sell our products. As a result, we may be found to infringe the intellectual property rights of others. The electronics industry is characterized by vigorous protection and pursuit of intellectual property rights or positions, which have resulted in significant and often protracted and expensive litigation. In the event of a successful claim of infringement against us and our failure or inability to license the infringed technology, our business and operating results could be adversely affected. Any litigation or claims, whether or not valid, could result in substantial costs and diversion of our resources. An adverse result from intellectual property litigation could force us to do one or more of the following:

cease selling, incorporating or using products or services that incorporate the challenged intellectual property;

33


 

cease selling, incorporating or using products or services that incorporate the challenged intellectual property;

obtain a license from the holder of the infringed intellectual property right, which license may not be available on reasonable terms, if at all; and

  
 

redesign products or services that incorporate the disputed technology.

If we are forced to take any of the foregoing actions, we could face substantial costs and shipment delays and our business could be seriously harmed. Although we carry general liability insurance, our insurance may not cover potential claims of this type or be adequate to indemnify us for all liability that may be imposed.

In addition, it is possible that our customers or end users may seek indemnity from us in the event that our products are found or alleged to infringe the intellectual property rights of others. Any such claim for indemnity could result in substantial expenses to us that could harm our operating results.

32


Our HSS technology is subject to government regulation, which could lead to unanticipated expense or litigation.

Our HyperSonic sound technology emits ultrasonic vibrations, and as such is regulated by the Food and Drug Administration. In the event of certain unanticipated defects in an HSS product, a customer or we may be required to comply with FDA requirements to remedy the defect and/or notify consumers of the problem. This could lead to unanticipated expense, and possible product liability litigation against a customer or us. Any regulatory impediment to full commercialization of our HSS technology, or any of our other technologies, could adversely affect our results of operations.

We may face personal injury and other liability claims that harm our reputation and adversely affect our sales and financial condition.

Some of our products are capable of sufficient acoustic output to cause damage to human hearing or human health if used improperly, such as when the products are used at close ranges or for long periods of exposure. A person injured in connection with the use of our products may bring legal action against us to recover damages on the basis of theories including personal injury, negligent design, dangerous product or inadequate warning. We may also be subject to lawsuits involving allegations of misuse of our products. Our product liability insurance coverage may be insufficient to pay all such claims. Product liability insurance may become too costly for us or may become unavailable for us in the future. We may not have sufficient resources to satisfy any product liability claims not covered by insurance which would materially and adversely affect our financial position. Significant litigation could also result in a diversion of management’s attention and resources, and negative publicity.

We may not be successful in obtaining the necessary licenses required for us to sell some of our products abroad.

Licenses for the export of certain of our products may be required from government agencies in accordance with various statutory authorities, including, for example, the Trading with the Enemy Act of 1917, the Arms Export Control Act of 1976, the Export Administration Act of 1979, or the International Emergency Economic Powers Act, as well as their implementing regulations and executive orders.

In the case of certain agreements involving equipment or services controlled under the International Traffic in Arms Regulations (ITAR) and sold at specified dollar volumes, the U.S. Department of State must notify Congress at least 15fifteen to 30thirty days, depending on the intended overseas destination, prior to authorizing these sales. During that time, Congress may take action to block the proposed sale. Based on our current product lines, we do not anticipate the congressional notification requirement to have an immediate impact; however, as our product lines expand, this notification requirement could impact our ability to sell certain controlled products or services in the international market.

The need for export licenses and, when required, Congressional notification, can introduce a period of delay in our ability to consummate international transactions. Because issuance of an export license is wholly within the discretion of the controlling U.S. government agency, it is possible that, in some circumstances, we may not be able to obtain the necessary licenses for some potential transactions.


Our operations could be harmed by factors including political instability, natural disasters, fluctuations in currency exchange rates and changes in regulations that govern international transactions.

We expect to sell orour products worldwide. The risks inherent in international trade may reduce our international sales and harm our business and the businesses of our customers and our suppliers. These risks include:

 

changes in tariff regulations;

  
 

political instability, war, terrorism and other political risks;

  
 

foreign currency exchange rate fluctuations;

  
 

establishing and maintaining relationships with local distributors and dealers;

  
 

lengthy shipping times and accounts receivable payment cycles;

  
 

import and export licensing requirements;

  
 

compliance with a variety of foreign laws and regulations, including unexpected changes in taxation and regulatory requirements;

  
 

greater difficulty in safeguarding intellectual property than in the U.S.; and

  
 

difficulty in staffing and managing geographically diverse operations.

33


These and other risks may preclude or curtail international sales or increase the relative price of our products compared to those manufactured in other countries, reducing the demand for our products.

Commercialization of our proprietary sound technologies depends on collaborations with other companies. If we are not able to maintain or find collaborators and strategic alliance relationships in the future, we may not be able to develop our proprietary sound technologies and products.

An important part of our strategy is to establish business relationships with leading participants in various segments of the electronics, government and sound reproduction markets to assist us in producing, distributing, marketing and selling products that include our proprietary sound technologies.

Our success will therefore depend on our ability to maintain or enter into new strategic arrangements with partners on commercially reasonable terms. If we fail to enter into such strategic arrangements with third parties, our financial condition, results of operations, cash flows and business prospects will be adversely affected. Any future relationships may require us to share control over our development, manufacturing and marketing programs or to relinquish rights to certain versions of our sound and other technologies.

We are dependent on third - party manufacturers. 

We do not have the capacity to manufacture all of our products internally and we are therefore dependent on third partythird-party manufacturers. At present, we manufacture NeoPlanar and SoundCluster internally only in small quantities and would need to outsource our manufacturing if sales of these products were to increase significantly. In addition, we establishedWe have historically used a manufacturing relationship with Pemstar, Inc. in fiscal 2004single third - party contract manufacturer to manufacture our LRADother products, and HSS products. We do not havewe intend to continue to use a formal written agreement with Pemstar. Pemstar, or any othersingle manufacturer for these products in the future. A contract manufacturing partner, may not be able or willing to manufacture products for us in the quantities and at the level of quality that we require. If we need to seek additional third partythird-party manufacturers for our products, we may not be able to obtain acceptable replacement manufacturing sources on a timely basis. An extended interruption in the supply of our products could result in a substantial loss of sales. In addition, any actual or perceived degradation of product quality as a result of our reliance on third partythird-party manufacturers may have an adverse effect on sales or result in increased product returns and buybacks. Failure to maintain quality contract manufacturing could reduce future revenues, adversely affecting financial condition and results of operations.


We rely on outside suppliers to provide a large number of components incorporated in our products.

Our products have a large number of components produced by outside suppliers. In addition, for certain of these items, we qualify only a single source, which can magnify the risk of shortages and decrease our ability to negotiate with our suppliers on the basis of price. In particular, we depend on our HSS piezo-film supplier to provide expertise and materials used in our proprietary HSS emitters. If shortages occur, or if we experience quality problems with suppliers, then our production schedules could be significantly delayed or costs significantly increased, which would have a material adverse effect on our business, liquidity, results of operation and financial position.

Our contracts and subcontracts that are funded by the U.S. government or foreign governments are subject to government regulations and audits and other requirements.

Government contracts require compliance with various contract provisions and procurement regulations. The adoption of new or modified procurement regulations could have a material adverse effect on our business, financial condition or results of operations or increase the costs of competing for or performing government contracts. If we violate any of these regulations, then we may be subject to termination of these contracts, imposition of fines or exclusion from government contracting and government-approved subcontracting for some specific time period. In addition, our contract and subcontract costs and revenues may be subject to adjustment as a result of audits by government auditors.

34


We derive revenue from government contracts and subcontracts, which are often non-standard, may involve competitive bidding, may be subject to cancellation with or without penalty and may produce volatility in earnings and revenue.

Our Government Group business has involved and is expected in the future to involve providing products and services under contracts or subcontracts with U.S. Federal,federal, state, local and foreign government agencies. Obtaining contracts and subcontracts from government agencies is challenging, and contracts often include provisions that are not standard in private commercial transactions. For example, government contracts may:

 

include provisions that allow the government agency to terminate the contract without penalty under some circumstances; 

  
 

be subject to purchasing decisions of agencies that are subject to political influence; 

  
 

contain onerous procurement procedures; and  

  
 

be subject to cancellation if government funding becomes unavailable.

Securing government contracts can be a protracted process involving competitive bidding. In many cases, unsuccessful bidders may challenge contract awards, which can lead to increased costs, delays and possible loss of the contract for the winning bidder.

If our key employees do not continue to work for us, our business will be harmed because competition for replacements is intense.

Our performance is substantially dependent on the performance of our executive officers and key technical employees, including Elwood G. Norris, our Chairman, and Kalani Jones, our President and Chief Operating Officer. We are dependent on our ability to retain and motivate high quality personnel, especially highly skilled technical personnel. Our future success and growth also depends on our continuing ability to identify, hire, train and retain other highly qualified technical, managerial and sales personnel. Competition for such personnel is intense, and we may not be able to attract, assimilate or retain other highly qualified technical, managerial or sales personnel in the future. The inability to attract and retain the necessary technical, managerial or sales personnel could cause our business, operating results or financial condition to suffer.

We may not address successfully the problems encountered in connection with any potential future acquisitions.


We expect to continue to consider opportunities to acquire or make investments in other technologies, products and businesses that could enhance our capabilities, complement our current products or expand the breadth of our markets or customer base. We have limited experience in acquiring other businesses and technologies. Potential and completed acquisitions and strategic investments involve numerous risks, including:

 

problems assimilating the purchased technologies, products or business operations;

   
 

problems maintaining uniform standards, procedures, controls and policies; 

   
 

unanticipated costs associated with the acquisition;

   
 

diversion of management’s attention from our core business;

   
 

adverse effects on existing business relationships with suppliers and customers;

   
 

risks associated with entering new markets in which we have no or limited prior experience;

   
 

potential loss of key employees of acquired businesses; and

   
 

increased legal and accounting costs as a result of the newly adopted rules and regulations related to the Sarbanes-Oxley Act of 2002.

If we fail to properly evaluate and execute acquisitions and strategic investments, our management team may be distracted from our day-to-day operations, our business may be disrupted and our operating results may suffer. In addition, if we finance acquisitions by issuing equity or convertible debt securities, our stockholders would be diluted.

35


We are subject to increased costs as a result of newly adopted accounting and SECSecurities and Exchange Commission regulations.

Pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, our management will be required by the end of fiscal 2005 to perform an evaluation of our internal control over financial reporting and have our independent auditor attest to that evaluation. Compliance with these requirements is expected to be expensive and time consuming. If we fail to timely complete this evaluation, or if our independent registered public accounting firm cannot timely attest to our evaluation, we could be subject to regulatory scrutiny and a loss of public confidence in our internal control over financial reporting.

In designing and evaluating our internal control over financial reporting, we recognize that any internal control or procedure, no matter how well designed and operated, can provide only reasonable assurance of achieving desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. No system of internal control can be designed to provide absolute assurance of effectiveness and any material failure of internal control over financial reporting could materially impact our reported financial results and the market price of our stock could significantly decline. In addition, adverse publicity related to a material failure of internal control over financial reporting would have a negative impact on our reputation and business.

Changes in stock option accounting rules may adversely impact our reported operating results prepared in accordance with generally accepted accounting principles, our stock price and our competitiveness in the employee marketplace.

Technology companies in general and our company in particular have a history of depending upon and using broad based employee stock option programs to hire, incentivize and retain employees in a competitive marketplace. Currently, we do not recognize compensation expense for stock options issued to employees or directors, except in limited cases involving modifications of stock options, and we instead disclose in the notes to our financial statements information about what such charges would be if they were expensed. An accounting standard setting body has recently adopted a new accounting standard that will require us to record equity-based compensation expense for stock options and employee stock purchase plan rights granted to employees based on the fair value of the equity instrument at the time of grant. We will be required to record these expenses beginning with our first quarter of fiscal 2006, which ends December 31, 2005. The change in accounting rules will lead to increased reported net loss or, should we become profitable, a decrease in reported earnings. This may negatively impact our future stock price. In addition, this change in accounting rules could impact our ability to utilize broad based employee stock plans to reward employees and could result in a competitive disadvantage to us in the employee marketplace.

There are a large number of shares that we sold in our 2005 Equity Financing that must be registered in a registration statement, and the sale of these shares may depress the price of our common stock.

To the extent that the investors in our 2005 Equity Financing sell shares of our common stock under an effective registration statement, our stock price may decrease due to the additional selling pressure in the market. The perceived risk of additional shares available for sale in the market may cause holders of our common stock to sell their shares, which could contribute to a decline in our stock price.

The sale of material amounts of shares by the 2005 Equity Financing selling stockholders could encourage short sales by third parties. These sales could contribute to the future decline of our stock price.

The sale of material amounts of common stock by selling stockholders under the registration statement for the 2005 Equity Financing could also encourage short sales by third parties. In a short sale, a prospective seller borrows stock from a stockholder or broker and sells the borrowed stock. The prospective seller hopes that the stock price will decline, at which time the seller can purchase shares at a lower price to repay the lender. The seller profits when the stock price declines because the seller can purchase the shares at a price which is lower than the price at which the seller sold the borrowed stock. Short sales could place downward pressure on the price of our common stock by increasing the number of shares being sold, which could contribute to the future decline of our stock price.


We may issue additional common stock in the future and this stock may reduce the value of your common stock.

We may issue additional shares of common stock without further action by our stockholders. Moreover, the economic and voting interests of each stockholder will be diluted as a result of such issuances. Although the number of shares of common stock that stockholders presently own will not decrease, such shares will represent a smaller percentage of our total shares that will be outstanding after such events.

Sales of common stock issuable on the exercise of outstanding options and warrants, may depress the price of our common stock.

As of July 18, 2005, we had outstanding options granted to our employees, directors and consultants to purchase 2,133,810 shares of our common stock, and had outstanding warrants issued to investors and others to purchase 3,890,153 shares of our common stock. The exercise prices for the options and warrants range from $2.00 to $11.00 per share. In the future we may issue additional convertible securities, options and warrants. The issuance of shares of common stock issuable upon the exercise of convertible securities, options or warrants could cause substantial dilution to holders of common stock, and the sale of those shares in the market could cause the market price of our common stock to decline. The potential dilution from these shares could negatively affect the terms on which we could obtain equity financing.

We may issue preferred stock in the future, and the terms of the preferred stock may reduce the value of your common stock.

We are authorized to issue up to 5,000,000 shares of preferred stock in one or more series. Our board of directors may determine the terms of future preferred stock offerings without further action by our stockholders. If we issue additional preferred stock, it could affect your rights or reduce the value of your common stock. In particular, specific rights granted to future holders of preferred stock could be used to restrict our ability to merge with or sell our assets to a third party. These terms may include voting rights, preferences as to dividends and liquidation, conversion and redemption rights, and sinking fund provisions.

Our stock price is volatile and may continue to be volatile in the future.

Our common stock trades on the NASDAQ SmallCap Market. The market price of our common stock has fluctuated significantly to date. In the future, the market price of our common stock could be subject to significant fluctuations due to general market conditions and in response to quarter-to-quarter variations in:

 

our anticipated or actual operating results;

   
 

developments concerning our sound reproduction technologies;

   
 

technological innovations or setbacks by us or our competitors;

   
 

conditions in the consumer electronics market;

   
 

announcements of merger or acquisition transactions;

   
 

changes in personnel within our company; and

   
 

other events or factors and general economic and market conditions.

The stock market in recent years has experienced extreme price and volume fluctuations that have affected the market price of many technology companies, and that have often been unrelated or disproportionate to the operating performance of companies.


Item 3. Quantitative and Qualitative Disclosures about Market Risk.

Market risk represents the risk of loss that may impact our financial position, results of operations or cash flows due to adverse changes in market prices, including interest rate risk and other relevant market rate or price risks. We do not use derivative financial instruments in our investment portfolio.

We are exposed to market risk associated with our issuance of a warrant to Kingsbridge Capital Limited for 275,000 shares. Because this warrant is classified as a liability on our balance sheet, we must calculate the fair value of the warrant at the end of each quarter and record the change in fair value over the quarter to other income or expense until the related registration statement is effective, until the warrant is fully exercised, or until the expiration of the warrant in June 2010. Accordingly, we are incurring risk associated with increases or decreases in the market price of our stock, which will directly impact the fair value calculation and the non-cash charge or credit recorded to our statement of operations for future quarters. For example, if our stock price increases by 20% during the quarter ending June 30, 2005 from its March 31, 2005 value, the registration statement is not effective and all other inputs into the Black-Scholes valuation model remain unchanged from March 31, 2005, we would record approximately $353,516 of other expense for the period ended June 30, 2005. If our stock price decreased by 20% during the quarter ending June 30, 2005 from its March 31, 2005 value, and all other inputs into the Black-Scholes valuation model remain unchanged from March 31, 2005, we would record approximately $330,763 as other income.

We are also exposed to some market risk through interest rates, related to our investment of current cash and cash equivalents of approximately $6.2 million.$2.4 million at June 30, 2005. Based on this balance, a change of one percent in interest rate would cause a change in interest income of $62,000.$24,000. The risk is not considered material and we manage such risk by continuing to evaluate the best investment rates available for short-term high quality investments.


Item 4. Controls and Procedures.

We maintain disclosure controls and procedures designed to ensure that material information related to us, including our consolidated subsidiaries, is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms.

(a)

As of the end of the period covered by this report, we carried out an evaluation under the supervision and with the participation of management, including our co-principal executive officers and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) under the Securities Exchange Act of 1934). Based upon that evaluation, our co-principal executive officers and principal financial officer concluded, as of the date of such evaluation, that the design and operation of such disclosure controls and procedures were effective, as of March 31,June 30, 2005.

  

(b)

Except as set forth below, no significant changes were made in our internal control over financial reporting (as defined in Rules 13a-15(f) or 15d-15(f) of the Exchange Act) during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. As a result of a notification from our independent registered accounting firm to our Audit Committee that we had not followed all appropriate period close down procedures for our quarter ended December 31, 2004, referencing deficient procedures for evaluation of the accrual for bonuses for which executives were eligible, we have rectified this significant deficiency by accelerating the timing of the Compensation Committee'sCommittee’s assessment for executive bonuses earned in the period.

Limitations. Our management, including our co-principal executive officers and principal financial officer, does not expect that our disclosure control or internal controls over financial reporting will prevent all errors or all instances of fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of control is based in part upon certain assumptions about the likelihood of future events, and any design may not succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures. Because of the inherent limitation of a cost-effective control system, misstatements due to error or fraud may occur and not be detected.


PART II. OTHER INFORMATION

Item 1.  Legal Proceedings.

Reference is made to Note 13 of our Notes to Interim Financial Statements included in Part I, Item 1 of this report for information regarding Legal Proceedings.

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3.  Defaults Upon Senior Securities.

Not applicable.


Item 4.  Submission of Matters to a Vote of Security Holders.

Not applicable.At the Company’s Annual Meeting of Stockholders held on April 28, 2005, the following individuals, all of the members of the Board of Directors were elected: Elwood G. Norris, Kalani Jones, Richard M. Wagner, David J. Carter and Daniel Hunter. For each elected director, the results of the voting were:

 Affirmative Votes Votes Withheld 
 
 
 
Elwood G. Norris18,356,226 133,565 
Kalani Jones18,361,088 128,703 
Richard M. Wagner18,270,422 219,369 
David J. Carter18,353,065 136,726 
Daniel Hunter18,388,270 101,521 

Our stockholders also voted to ratify the selection of BDO Seidman, LLP as our independent auditors for the fiscal year ending September 30, 2005. The results of the voting on this proposal were:

Affirmative Votes
 
Negative Votes
 
Abstentions
 
Broker Non-Votes
 

 
 
 
 
18,352,033 119,771 17,987 -0- 

The foregoing proposal was approved and accordingly ratified.

Our stockholders also voted to approve the American Technology Corporation 2005 Equity Incentive Plan. The results of the voting on this proposal were:

Affirmative Votes
 
Negative Votes
 
Abstentions
 
Broker Non-Votes
 

 
 
 
 
8,251,891 629,311 88,615 9,519,974 

The foregoing proposal was approved.

Item 5.  Other Information.

On May 9,August 5, 2005, Carl Gruenler, Vice President, Governmentour Compensation Committee approved amendments to our 2005 Equity Incentive Plan and Force Protection Systems Group, leftstandard forms of Stock Option Agreement and Stock Award Agreement for the 2005 Equity Incentive Plan. The amendments were made in response to comments of the California Department of Corporations in connection with our company. Mr. Gruenler had been employed underapplication for qualification of the terms2005 Equity Incentive Plan in California. The amendments included a modification of the definition of Change in Control to narrow the circumstances defined as a letterChange in Control, and clarifications that any right of repurchase we might reserve in an award agreement amended on July 30, 2003. The letterand any rights of transferability we might permit in an award agreement, provided for an annual base salary of $110,000, and an annual performance bonus of upmust conform to 10% of base salary to be determinedlimitations contained in regulations promulgated by the Compensation CommitteeCalifornia Department of Corporations. The amended 2005 Equity Incentive Plan and the Boardstandard forms of Directors. Mr. Gruenler's annual base salary at the time of separation was $250,000,Stock Option Agreement and he participated in our broad-based commission plan in lieu of the annual performance bonus contemplated by his letter agreement. Mr. Gruenler's employment was terminable at-will by us or by Mr. Gruenler for any reason, with or without notice. Our employment arrangement with Mr. Gruenler was terminated in conjunction with his departure.Stock Award Agreement are attached to this report as Exhibits 10.9, 10.11 and 10.12.

The foregoing disclosure is made in lieu of disclosure under Item 1.021.01 on Form 8-K.

As disclosed in Note 11 to our financial statements included in this report, as a result of our decision in June 2005 to terminate the Committed Equity Financing Facility with Kingsbridge Capital Limited, we determined that the prepaid transaction costs asset associated with the fair value of the warrant issued to Kingsbridge and the legal, audit and other fees associated with the financing, was impaired at June 30, 2005. Accordingly, we recognized an impairment charge in the total amount of $477,085, $293,826 of which represents legal, audit and associated fees and is recorded as selling, general and administrative expense for the three and nine months ended June 30, 2005, and $183,259 of which represents the excess of the fair value of the warrant over the associated derivative instrument liability and is recorded as a warrant impairment expense for the three and nine months ended June 30, 2005. The remaining asset of $659,846 in prepaid transaction costs will be offset against the derivative instrument liability of the same amount in the quarter ending September 30, 2005, with no net effect on other income or expense.

The foregoing disclosure is made in lieu of disclosure under Item 2.06 on Form 8-K.


Item 6.  Exhibits

 

10.1

Table of Inducement Grants.

Separation and Release Agreement with Carl Gruenler. Filed as Exhibit 99.1 to the Registrant’s Form 8-K filed June 17, 2005. +
   
 

10.2

Offer Letter for Bruce Gray. +

Consulting Agreement with Carl Gruenler. Filed as Exhibit 99.2 to the Registrant’s Form 8-K filed June 17, 2005.
   
 10.3Inducement Stock Option Grant NoticeTermination, Settlement and Inducement Stock OptionRelease Agreement for Bruce Graywith Kingsbridge Capital Limited dated March 22,as of July 8, 2005.
10.4Securities Purchase Agreement dated July 14, 2005. Filed as Exhibit 99.1 to the Registrant’s Form 8-K filed July 19, 2005.
10.5Registration Rights Agreement dated July 14, 2005. Filed as Exhibit 99.2 to the Registrant’s Form 8-K filed July 19, 2005.
10.6Form of Warrant-A issued July 18, 2005. Filed as Exhibit 99.3 to the Registrant’s Form 8-K filed July 19, 2005.
10.7Form of Warrant-B issued July 18, 2005. Filed as Exhibit 99.4 to the Registrant’s Form 8-K filed July 19, 2005.
10.8Engagement letter dated July 15, 2005. Filed as Exhibit 99.5 to the Registrant’s Form 8-K filed July 19, 2005.
10.92005 Equity Incentive Plan as amended August 5, 2005. +
   
 

10.4

10.10

Summary SheetForm of Director and Executive Officer Compensation.Stock Option Agreement under the 2005 Equity Incentive Plan for grants prior to August 5, 2005. Filed as Exhibit 99.2 to the Registrant’s Form S-8 filed June 2, 2005. +

   
 

31.1

10.11

Form of Stock Option Agreement under the 2005 Equity Incentive Plan for grants on or after August 5, 2005. +

10.12Form of Stock Award Agreement under the 2005 Equity Incentive Plan. +
10.13Summary Sheet of Director and Executive Officer Compensation. +
10.14Agreement of Settlement and Mutual Release, dated April 27, 2005, with eSoundIdeas, Inc., SoundIdeas, Greg O. Endsley, Douglas J. Paschall and Gordon & Holmes.
10.15Registration Rights Agreement, dated April 27, 2005, with Greg O. Endsley, Douglas J. Paschall and Gordon & Holmes.
31.1Certification of Elwood G. Norris, Co-Principal Executive Officer, pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

   
 

31.2

Certification of Kalani Jones, Co-Principal Executive Officer, pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

   
 

31.3

Certification of Michael A. Russell, Principal Financial Officer, pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

   
 

32.1

Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by Elwood G. Norris and Kalani Jones, Co-Principal Executive Officers, and Michael A. Russell, Principal Financial Officer.

  
 

+ Management contract or compensatory plan or arrangement.  


SIGNATURESSIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

  AMERICAN TECHNOLOGY CORPORATION
  
    
  By:/S/ MICHAEL A. RUSSELL
    
Date:  May 10,August 9, 2005  Michael A. Russell, Chief Financial Officer
(Principal Financial and Accounting Officer
and duly authorized to sign on behalf of
the Registrant)

Exhibit Index  

 

10.1

Table of Inducement Grants.

Separation and Release Agreement with Carl Gruenler. Filed as Exhibit 99.1 to the Registrant’s Form 8-K filed June 17, 2005. +
   
 

10.2

Offer Letter for Bruce Gray. +

Consulting Agreement with Carl Gruenler. Filed as Exhibit 99.2 to the Registrant’s Form 8-K filed June 17, 2005.
   
 10.3Inducement Stock Option Grant NoticeTermination, Settlement and Inducement Stock OptionRelease Agreement for Bruce Graywith Kingsbridge Capital Limited dated March 22,as of July 8, 2005.
10.4Securities Purchase Agreement dated July 14, 2005. Filed as Exhibit 99.1 to the Registrant’s Form 8-K filed July 19, 2005.
10.5Registration Rights Agreement dated July 14, 2005. Filed as Exhibit 99.2 to the Registrant’s Form 8-K filed July 19, 2005.
10.6Form of Warrant-A issued July 18, 2005. Filed as Exhibit 99.3 to the Registrant’s Form 8-K filed July 19, 2005.
10.7Form of Warrant-B issued July 18, 2005. Filed as Exhibit 99.4 to the Registrant’s Form 8-K filed July 19, 2005.
10.8Engagement letter dated July 15, 2005. Filed as Exhibit 99.5 to the Registrant’s Form 8-K filed July 19, 2005.
10.92005 Equity Incentive Plan as amended August 5, 2005. +
   
 

10.4

10.10

Summary SheetForm of Director and Executive Officer Compensation.Stock Option Agreement under the 2005 Equity Incentive Plan for grants prior to August 5, 2005. Filed as Exhibit 99.2 to the Registrant’s Form S-8 filed June 2, 2005. +

   
 

31.1

10.11

Form of Stock Option Agreement under the 2005 Equity Incentive Plan for grants on or after August 5, 2005.+

10.12Form of Stock Award Agreement under the 2005 Equity Incentive Plan. +
10.13Summary Sheet of Director and Executive Officer Compensation. +
10.14Agreement of Settlement and Mutual Release, dated April 27, 2005, with eSoundIdeas, Inc., SoundIdeas, Greg O. Endsley, Douglas J. Paschall and Gordon & Holmes.
10.15Registration Rights Agreement, dated April 27, 2005, with Greg O. Endsley, Douglas J. Paschall and Gordon & Holmes.
31.1Certification of Elwood G. Norris, Co-Principal Executive Officer, pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

   
 

31.2

Certification of Kalani Jones, Co-Principal Executive Officer, pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

   
 

31.3

Certification of Michael A. Russell, Principal Financial Officer, pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

   
 

32.1

Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by Elwood G. Norris and Kalani Jones, Co-Principal Executive Officers, and Michael A. Russell, Principal Financial Officer.

  
 

+ Management contract or compensatory plan or arrangement.  

42